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I may not have gone where I intended to go, but I think 
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1 ABSTRACT 
Acute  kidney  injury  (AKI)  is  a  rapid  loss  of  kidney  function,  which  can  be  a  
consequence of ischemic, toxic or obstructive insult to the tubules, a reduction of 
the filtering capacity of the glomeruli or tubulointerstitial inflammation. The 
diagnosis  and  prognosis  of  AKI  are  problematic  due  to  the  lack  of  sufficiently  
specific and sensitive markers. The aims of these studies were to assess how 
kidney  impairment  impacts  on  the  urinary  proteome  and  to  reveal  the  
pathophysiological processes in kidney tissue caused by toxic insult. Changes in 
the  urine  proteome  after  toxic  insult  to  the  kidneys  were  studied  by  measuring  
urine enzyme activities, total protein and creatinine concentrations, and using 
proteomic methods. The usefulness of urinary enzyme activities in kidney 
impairment  diagnosis  was  studied  with  in  dogs  bitten  by  Vipera berus berus 
(common European adder) and in sheep with ketoprofen-induced AKI. In both 
cases, the urinary enzyme activities were demonstrated to be promising markers 
of kidney impairment.  
Two-dimensional gel electrophoresis (2D-GE) and two-dimensional 
differential gel electrophoresis (2D-DIGE) were used to detect potential new 
urinary protein markers in diagnosing AKI resulting from intoxication in sheep 
and dogs. The detected differentially expressed proteins were identified using a 
peptide mass fingerprinting method with either a matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometer (MALDI-TOF) or a liquid 
chromatograph hybrid quadrupole mass spectrometer (LC-MS/MS). As a result, 
several potential urinary markers of kidney impairment were identified: retinol 
binding protein 4, calbindin D28k, CD1d, complement C3 and complement C4 in 
our sheep model of AKI, and alpha-1-antirypsin, ?-2-microglobulin, fetuin-B and 
superoxide dismutase (Cu-Zn) in dogs bitten by the common European adder. 
The  pathophysiological  process  in  kidney  tissue  in  renal  impairment  was  
examined using immunohistochemical methods. The possible involvement of 
calbindin D28k, CD1d and complement (C) components in the pathophysiology of 
AKI  in  our  sheep  model  was  also  investigated.  All  antigens  were  localized  in  
kidney  tubule  epithelial  cells  and  the  tubular  lumina  of  the  exposed  sheep,  
confirming acute tubular injury detected by histological stains. 
In  summary,  the  measurement  of  urine  enzyme  activities  proved  to  be  an  
efficient  method  to  evaluate  kidney  function  in  two  domestic  animal  species.  
Several potential urinary markers were found, and warrant further investigation 
in clinical veterinary patients suffering from kidney impairment. The complement 
system was activated in kidney tissue in the ketoprofen-induced sheep model of 
AKI.     
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3 ABBREVIATIONS 
 
1D-GE One-dimensional gel electrophoresis 
2D-DIGE Two-dimensional difference gel electrophoresis 
2D-GE  Two-dimensional gel electrophoresis 
?2MG ?2-Microglobulin 
AAT Alpha-1-antitrypsin  
ACP Acid phosphatase 
AKI Acute kidney injury 
ALP Alkaline phosphatase 
AST Aspartate aminotransferase 
ATI Acute tubular injury 
BSA Bovine serum albumin 
C Complement 
CNS Central nervous system 
COX Cylooxygenase 
DAB 3,3?-Diaminobenzidine 
FABP Fatty acid-binding protein  
ELISA Enzyme-linked immunosorbent assay 
ESRF End-stage renal failure 
GFR Glomerular filtration rate 
GGT Gamma-glutamyl transpeptidase 
HMW High-molecular-weight protein 
HPLC High-performance liquid chromatography 
IEF  Isoelectric focusing 
IL-18 Interleukin-18 
IMW Intermediate-molecular-weight protein 
IPG  Immobilized pH gradient 
LC  Liquid chromatography 
LDH Lactate dehydrogenase 
LMW Low-molecular-weight protein 
MALDI  Matrix-assisted laser desorption/ionization 
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MDRD  Modification of Diet in Renal Disease 
MS  Mass spectrometry 
NGAL Neutrophil gelatinase-associated lipocalin 
NSAID Nonsteroidal anti-inflammatory drug 
NKT Natural killer T-cells 
PAGE  Polyacrylamide gel electrophoresis 
PAS Periodic acid Schiff stain 
PG Prostaglandins 
PGD2 Prostaglandin D2 
PGE2 Prostaglandin E2 
PGF2? Prostaglandin F2? 
PGG2 Prostaglandin G2 
PGH2 Prostaglandin H2 
pI  Isoelectric point 
PMF  Peptide mass fingerprinting 
RBP4 Retinol binding protein 4 
ROS Reactive oxygen species 
SDS-PAGE  Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SOD1 Superoxide dismutase 1 
TBS Tris-buffered saline 
TOF  Time of flight 
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4 INTRODUCTION 
Kidneys serve essential regulatory roles, notably urine secretion, in most 
vertebrates.  In  mammals,  they  are  located  in  the  abdominal  cavity  outside  the  
peritoneum. Each kidney is surrounded by the renal fascia, a layer of connective 
tissue  composed  of  a  fibrous  capsule  and  fat  tissue  known as  perirenal  fat.  The  
parenchyma of  the  kidneys  is  formed of  cone-shaped  renal  pyramids,  the  broad  
bases  of  which  face  towards  the  cortex.  The  urine-producing  functional  
structures,  the  nephrons,  are  located  through  the  cortex  and  medulla,  and  are  
composed  of  the  glomerulus,  proximal  tubule,  loop  of  Henle,  distal  tubule  and  
collective  duct.  The  glomerulus  consists  of  a  tuft  of  capillaries  enveloped  by  
spherical double-walled capsule (Bowman’s capsule).  
Urine, the secretion of kidneys, is a waste product of the body. However, 
urine is an ideal biological sample for the discovery of biomarkers, as it is easy to 
collect without any invasive procedures. Urinary proteomics is one of the fastest 
growing subdisciplines of proteomics in biomedical research (Thongboonkerd, 
2010),  and  it  is  used  not  only  in  kidney  disease  biomarker  research  but  also  in  
investigating other organ disorders and systemic diseases in humans, such as 
diabetic nephropathy (Rao et al., 2007), bladder cancer (Goodison et al., 2009), 
colorectal liver metastasis (Bröker et al., 2013) and atherosclerosis in humans and 
mice (von zur Muhlen et al., 2012). As urine is a result of the filtration of plasma, 
its contents can vary depending on the primary reason for kidney impairment. It 
is important to understand which urinary proteins could serve as generic markers 
for kidney impairment, preferably distinguishing glomerular and tubular 
proteinuria from one another, and which markers are specific to a certain disease 
and reflect the general state of the individual.  
In proteomic studies it is important that the results are interpreted with 
caution, as certain proteins seem to predominate the list of differentially 
expressed proteins in the majority of studies, irrespective of the disease or species 
(Petrak et al., 2008). Biomarker identification, validation and implementation are 
challenging  (Mischak  et  al.,  2010;  Mischak  et  al.,  2012).  The  bottleneck  in  the  
biomarker  pipeline  is  the  validation  step  with  other  diseases  to  determine  the  
specificity  and  sensitivity  of  the  marker  to  the  target  disease.  The  majority  of  
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published proteomic studies have involved small single-centre trials, while the 
validation  step  requires  larger  trials  with  heterogeneous  study  populations.  The  
majority of interesting novel urinary biomarkers of acute kidney injury (AKI) are 
low-abundance proteins discovered using effective proteomic methods. In clinical 
settings,  the  use  of  these  laborious  and  expensive  methods  is  problematic,  and  
there is a demand for more cost-effective methods that yield rapid results.  
Methods  based  on  antibodies,  such  as  enzyme  immunoassays  (EIA),  are  
used  to  validate  the  results  from  the  proteomic  approach.  The  majority  of  
proteins are subjected to alternative splicing and post-translational 
modifications, altering the composition of isoforms. Antibodies usually recognize 
particular  epitopes  of  a  protein,  and  if  only  a  particular  isoform  of  a  protein  is  
relevant to a certain disease,  validation with immunological  methods can fail.  A 
combination of several markers appears to have greater diagnostic and predictive 
capabilities in humans than any single biomarker (Han et al., 2008; Vaidya et al., 
2008; Metzger et al., 2010; Hall et al., 2011). 
Intoxications caused by a snake bite or an accidental overdose of NSAIDs are 
common in domestic animals, especially dogs. These accidents can lead to AKI, a 
life-threatening condition in which early diagnosis is problematic and mortality is 
high.  AKI  is  generally  defined  as  a  decline  in  renal  function  resulting  in  an  
accumulation of nitrogenous and non-nitrogenous waste products in the blood 
circulation (Venkataraman and Kellum, 2007). It is usually caused by an ischemic 
or  toxic  insult  that  results  in  damage  to  the  proximal  tubules  (Silva,  2004).  In  
ischemic-reperfusion AKI, both innate and adaptive immune systems are active 
and contribute to pathophysiological  changes in the kidney tissue (Kinsey et  al.,  
2008). Routinely used parameters, such as serum creatinine and urea 
concentrations, are insensitive and non-specific to acute changes in kidney 
function and kidney injury. They have a minor prognostic value in AKI, which is a 
genuine  problem  in  clinical  veterinary  medicine.  The  early  detection  of  AKI  is  
essential for effective treatment and the prognosis, but the traditional laboratory 
approach for AKI, such as measuring serum creatinine and urea concentrations, 
generates a time gap between injury and a significant increase in these indicators.  
Thus,  sensitive,  early  biomarkers  are  needed  to  detect  those  patients  with  or  at  
risk of AKI to enable early intervention and the prevention of injury. Biomarkers 
may  also  serve  several  other  purposes,  such  as  identifying  AKI  aetiologies  and  
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predicting  AKI  severity.  The  ideal  biomarker  would  allow  the  discrimination  of  
patients at risk of AKI before the insult to kidney tissue and true AKI patients. For 
clinical use, biomarkers should be straightforward to measure from samples that 
are easily accessible. Several published studies have revealed novel urinary 
biomarkers associated with various kidney diseases in humans and animals 
(Metzger  et  al.,  2010;  Varghese  et  al.,  2010;  Nabity  et  al.,  2011;  Sirota  et  al.,  
2013). 
The research presented in this thesis suggested and tested potential urinary 
markers for assessing kidney impairment after  certain intoxications in domestic  
animals before the routinely used parameters react.  
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5 REVIEW OF THE LITERATURE 
5.1 THE EXCRETION AND ABSOBTION OF URINARY 
PROTEIN 
 
The  main  function  of  glomeruli  in  the  kidney  is  to  filter  low-molecular-weight  
substances  from  the  blood  to  the  urine  and  at  the  same  time  retain  larger  
macromolecules in the blood flow. Filtered substances have to pass three barriers 
in  the  glomerulus,  which  together  form  a  highly  selective  sieving  filter,  before  
entering the tubular compartment: the endothelium of the glomerular capillaries, 
the glomerular basement membrane and podocytes. The first barrier, the 
endothelial cell surface of glomerular capillaries containing glycocalyx, is a 
plasma membrane-bound part of the barrier composed of glycoproteins, 
glycosaminoglygans (GACs) and proteoglycans (Rennke et al., 1975). The second 
barrier, the basement membrane, is a three-layer structure comprised of a 
heteropolymeric network of type IV collagen, laminin, fibronectin, entactin and 
heparin sulphate proteoglycans (Laurie et al., 1984). The third barrier consists of 
the  epithelial  cells  covering  the  outer  surface  of  the  glomerular  capillaries  and  
facing Bowman’s capsule, called podocytes. Between individual podocytes are 
filtration slits filled with glycocalyx (Kerjaschki, 1994). The endothelial glycocalyx 
contributes to the permeability of the capillary wall (Singh et al., 2007). Although 
the  exact  mechanism  of  glomerular  passage  of  plasma  proteins  is  still  unclear,  
proteins  are  filtered  from  primary  urine  based  on  their  size,  weight  and  shape  
(Haraldsson and Sörensson, 2004).  
The  reabsorption  of  proteins  takes  place  in  the  proximal  tubule,  where  the  
epithelial cells represent an effective apical endocytic apparatus (D’Amigo and 
Bazzi,  2003).  Abundant serum proteins,  such as albumin,  immunoglobulin light 
chain, transferrin, vitamin D-binding protein and myoglobin, are reabsorbed in 
the proximal renal tubules, mainly by the endocytic receptors megalin and cubilin 
(Maunsbach, 1966; Cui et al., 1996; Batuman et al., 1998; Burne et al., 1999; 
Christensen and Gburek,  2004).  The reabsorbed proteins are transported inside 
vesicles  to  the  endosomal  compartment  of  the  epithelial  cells,  and  fused  with  
Review of the literature  
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endosomes, where degradation of these proteins takes place. The degradation 
products, amino acids, are returned to the circulation (Carone et al., 1979).   
Even  though  the  protein  concentration  of  urine  from  healthy  individuals  is  
1000 times less than that of plasma, with proteomic methods approximately 1500 
separate proteins have been detected in urine (Pieper et al., 2004; Adachi et al, 
2006). In a study by Pieper et al. (2004), the urine proteins were separated into 
two  sample  groups  according  to  their  size  before  identification  by  mass  
spectrometry. Plasma-derived proteins constitute only one-third of the circa 420 
identified  proteins.  A  study  by  Adachi  et  al.  (2006)  revealed  that  urine  from  
healthy humans contains an enriched portion of extracellular and, surprisingly, 
also plasma membrane and lysosomal proteins.  
5.2 ACUTE KIDNEY INJURY 
 
AKI  is  generally  defined  as  a  rapid  loss  of  nephron  function  resulting  in  an  
accumulation of nitrogenous and non-nitrogenous waste products 
(Venkataraman  and  Kellum,  2007).  The  causes  of  AKI  in  humans  include  
complex  surgery,  nephrotoxic  medication,  sepsis  and  non-renal  disease,  and  in  
developing countries also diarrhoea, infections, animal venoms, septic abortion, 
dyes and natural medicines (Fortenberry et al., 2013; Li et al., 2013). In dogs and 
cats, common complications leading to AKI include ischemia, infarction, toxins, 
infectious disease, bladder rupture, hypercalcaemia, hyperviscosity, multiple 
organ dysfunction, sepsis, pneumonia and acute pancreatitis (Ross, 2011; Thoen 
and  Kerl,  2011).  The  prognosis  depends  greatly  on  the  cause  of  AKI  in  both  
humans  and  animals.  The  mortality  rate  in  dogs  is  approximately  53%  to  60%  
(Behrend  et  al.,  1996;  Vaden  et  al.,  1997;  Segev  et  al.,  2008),  and  in  cats  50%  
(Worwang and Langston, 2008).  
AKI  can  evolve  from  ischemic,  toxic  or  obstructive  insult  to  renal  tubules,  
tubulointerstitial processes with inflammation, or a reduced filtering capacity of 
the  glomerulus  (Thadhani  et  al.,  1996).  A  lowered  GFR  followed  by  altered  
protein traffic in the kidney can induce tubulointerstitial inflammation and 
therefore contribute to the progression of kidney injury (Abbate et al., 1998). 
Tubular  cells  can  be  further  damaged  by  various  components,  such  as  growth  
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factors, albumin and complement components in the proteinuric flow. 
Tubulointerstitial damage can lead to a decrease in GFR via several mechanisms. 
When  damage  occurs,  it  will  1)  increase  fluid  delivery  to  the  macula  densa  and  
affect  the  tubuloglomerular  feedback  system  (Bohle  et  al.,  1987),  2)  lead  to  
atubular glomeruli and therefore reduce the total number of functional nephrons 
(Marcussen  1992),  and  3)  lead  to  the  elimination  of  postglomerular  capillaries,  
resulting in ischemic renal injury (Nangaku, 2004). As a result of these processes, 
proteinuria develops.  
5.3 PROTEINURIA 
 
Renal  proteinuria  can  result  from  glomerular  or  tubular  impairment.  Roughly  
speaking,  the  leakage  of  HMW  proteins  (e.g.  >69  KDa)  to  urine  indicates  
glomerular proteinuria resulting from disturbed glomerular filtration, and the 
leakage  of  LMW  proteins  (e.g.  <  60  KDa)  to  tubular  proteinuria  resulting  from  
disturbed protein reabsorption (Bazzi et al., 1997). Selective proteinuria, where 
IMW proteins, mainly albumin, are passed through the glomerular barrier 
together  with  LMW  proteins,  is  a  result  of  moderate  changes  in  glomerular  
permeability  (Joachim  et  al.,  1964).  Disturbance  of  the  glycocalyx  in  the  
glomerulus leads to altered glomerular permeability and proteinuria via reduced 
a  charge,  and  to  some  extent,  size  and  selectivity  (Jeansson  and  Haraldsson,  
2003; Fridén et al., 2011; Salmon et al., 2012). Several studies have demonstrated 
that  the  glomerular  pore  distribution  changes  in  developing  proteinuria  so  that  
more  HMW  and  IMW  proteins  pass  through  the  glomerular  barrier  (Scandling  
and  Myers,  1992;  Ruggenenti  et  al.,  1999;  Bakoush  et  al.,  2002;  Lemley  et  al.,  
2002). 
Proteinuria further promotes tubulointerstitial damage, inducing 
apoptosis,  and  therefore  plays  an  essential  role  in  the  progression  of  end-stage  
renal disease (Remuzzi and Bertani, 1998; Thomas et al., 1999; Ohse et al., 2006). 
As  a  result  of  tubular  injury,  the  excretion  of  a  progressively  larger  fraction  of  
LMW proteins is manifested (D’Amico and Bazzi, 2003). Work conducted with an 
in vitro model  of  tubular  epithelial  cells  has  implied  that  proteinuria  activates  
inflammatory  and  vasoactive  molecules,  such  as  chemokine  monocyte  
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chemoattractant protein-1 (MCP-1) (Wang et  al.,  1997;  Zoja et  al.,  1998,  Yard et  
al.,  2001;  Donadelli  et  al.,  2003).  Overload  proteinuria  in  rats  induces  the  
production of MCP-1 in the renal tubules in vivo,  suggesting that monocytes are 
recruited  to  the  site  of  injury  (Eddy  and  Giachelli,  1995).  Complement  
components  have  also  been  detected  in  the  urine  in  patients  suffering  from  
proteinuria, and complement activation has been thought to be at least partly 
responsible for tubular injury (Camussi et al., 1982; Camussi et al., 1985; 
Biancone et  al.,  1994; Khan and Sinniah,  1995;  Morita et  al.,  2000).  Astor et  al.  
(2011)  reported  in  human  patients  with  chronic  kidney  disease  that  a  low  GFR  
together with albuminuria was associated with mortality and end-stage renal 
disease.  In  human  patients  with  primary  glomerulonephritis,  the  tubular  
proteinuria is more often associated with ESRF than in patients with glomerular 
proteinuria (Bazzi et al., 1997). Controversially, human patients with clinical AKI 
and glomerular proteinuria developed chronic or end-stage renal failure more 
often than patients with tubular proteinuria (Suhail et al., 2011). It appears that 
independently  of  the  initial  insult  on  the  kidneys,  the  progressive  process  of  
parenchymal damage paves the way for terminal renal failure both in glomerular 
and tubular proteinuria (Remuzzi et al., 1997). 
5.4 LABORATORY ASSESSMENT OF KIDNEY FUNCTION 
5.4.1 BLOOD 
 
The plasma creatinine concentration is probably the most widely used analyte to 
evaluate kidney function. Creatinine is a product of creatine and phospocreatine 
metabolism. It is freely filtered by the glomerulus and does not bind to proteins. 
Factors  such  as  age,  gender,  muscle  mass  and  hydration  status  can  alter  the  
creatinine concentration. In dogs, the plasma concentration of creatinine appears 
to be higher in sight hound breeds such as Greyhounds (Hilppö 1986; Freeman et 
al.,  2003).  Other  factors  that  have  been  reported  to  alter  the  plasma  creatinine  
concentration in dogs include living outside (Rautenbach and Joubert, 1988), the 
circadian rhythm (Sothern et al., 1993), the site of blood sampling (Jensen et al., 
1994)  and  physical  effort  (Snow  et  al.,  1988;  Rose  and  Bloomberg,  1989;  
Hinchcliff  et  al.,  1993).  In human medicine,  the GFR is  calculated by measuring 
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serum creatinine and usually using either the Cockcroft-Gault or MDRD formula 
to estimate creatinine clearance (Cockcroft and Gault, 1976; Levey et al., 1999). In 
veterinary medicine, kidney function can be evaluated by two means: either 
measuring the plasma urea and creatinine concentration, or measuring the GFR 
by  clearance  methods  using  indicators  such  as  inulin  or  iohexol  (Gleadhill  and  
Michell, 1996; Brown et al., 1996; Haller et al., 1998).  
In  human  medicine,  the  RIFLE  system  is  used  to  assess  the  severity  of  AKI  
based on the alteration in the serum creatinine concentration from the baseline or 
by  measuring  urine  output  (Hoste  et  al.,  2006).  The  acronym RIFLE is  derived  
from  the  terms  risk,  injury,  failure,  loss  and  end  stage  in  relation  to  kidney  
function. Although veterinary medicine lacks such an established staging system, 
there have been a few attempts to develop such criteria.  Segev et al. (2008) 
introduced a scoring system for dogs managed with haemodialysis based on 
multiple variables, including plasma creatinine. Thoen and Kerl (2011) proposed 
a novel staging system, Veterinary Acute Kidney Injury (VAKI), for dogs based on 
serum creatinine concentration changes from baseline samples, as seen in the 
RIFLE  system.  Table  1  summarizes  the  two  existing  staging  systems  based  on  
serum creatinine: RIFLE in humans and VAKI in dogs. 
 
  
Review of the literature  
18 
Table 1. The RIFLE system for humans and VAKI system for dogs used to 
evaluate the severity of AKI based on alterations in the serum creatinine 
concentration from the baseline. 
 
 
RIFLE Staging VAKI 
- - 0 <1.5-fold increase in S-crea 
1.5-fold increase in S-crea 
 
Risk 1 1.5-1.99-fold increase in S-crea 
2-fold increase in S-crea Injury 2 2-2.9-fold increase in S-crea 
3-fold increase in S-crea 
OR 
Absolute creatinine ?354 
µmol/L 
Failure 3 ?3-fold increase in S-crea 
OR 
Absolute creatinine >354 
µmol/L 
Total loss of kidney function 
> 4 weeks 
Loss - - 
Renal replacement therapy 
needed 
End Stage - - 
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5.4.2 URINARY PROTEINS 
 
Measurement of the urine creatinine concentration is not valid in itself to 
evaluate kidney function. As creatinine is freely and mostly evenly excreted to 
primary urine, it serves as a marker for urine dilution. Other parameters 
measured from urine are therefore expressed as creatinine ratios. The urine 
protein:creatinine ratio, together with the urine albumin:creatinine ratio, is used 
to screen for kidney impairment resulting from several conditions in humans, 
including preeclampsia (Durnwald and Mercer, 2003) and diabetic nephropathy 
(Rodby et al., 1995).  
Sensitive and specific biomarkers are needed in kidney impairment 
diagnosis.  Preferably,  a  biomarker  of  acute  kidney  injury  should  be  able  to  1)  
detect the injury at an early stage, 2) distinguish glomerular and tubular injury, 3) 
distinguish renal  and nonrenal  injury,  4)  assess the severity of  the injury and 5)  
assess the effect  of  treatment (Nguyen and Devarajan,  2008).  To be practical  in 
clinical  settings,  a  biomarker should be easy to detect  and the sample should be 
noninvasively obtained. Decramer et al. (2008) summarized the advantages and 
disadvantages  of  urine  as  a  sample  matrix  for  proteomic  studies.   As  an  
advantage:  1)  urine  is  easily  available  and  can  be  repeatedly  collected  in  large  
quantities, 2) the proteins are relatively stable, since endogenous proteolytic 
activity  has  taken  its  course  at  the  time  of  voiding,  3)  the  LMW  proteins  are  
usually  soluble  and  therefore  suitable  for  proteomic  analysis  without  extensive  
treatment, 4) for kidney impairment diagnosis, urine is in close contact with the 
site  of  injury.  As  a  disadvantage,  the  urinary  proteome  varies  widely,  resulting  
from  variations  in  the  diet  and  fluid  intake,  metabolic  or  catabolic  processes,  
circadian rhythms and exercise, as well as circulatory levels of various hormones 
(Decramer et al., 2008).  
For the discovery of novel urinary biomarkers of kidney impairment, 
proteomics has opened up new possibilities. The proteome is a set of proteins 
expressed in a cell,  tissue or organism at  a  given time (Pennington et  al.,  1997).  
Proteomics offers a systematic multivariate analysis of proteins to identify, 
quantify  and  assess  them  functionally  (Peng  and  Gygi,  2001).  Two  different  
approaches are used in the detection of  proteins.  In the gel-based approach,  the 
proteins  are  separated  according  to  their  size  with  1D-GE,  or  their  size  and  pI  
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with 2D-GE, a technique that allows the visualization of several thousands of 
proteins using a wide pH range IPG strip, and even more using overlapping 
narrow pH range IPG strips (Wildgruber et al., 2000; Westbrook et al., 2001). 
With 2D-DIGE, the differences between proteins can be quantified (Unlü et al., 
1997). Interesting proteins are then identified using mass spectrometry. The gel-
free approach utilizes high-throughput mass spectrometry, and no separation of 
proteins takes place before analysis. In a review by Aebersold and Mann (2003), a 
variety of gel-free methods were discussed.  
In the literature, there are several potential urinary markers whose 
applicability for diagnosing AKI in humans and animals has been assessed. 
Several urinary enzymes excreted from the proximal tubules have been indicated 
to  be  a  reliable  choice  for  diagnosing  renal  impairment:  GGT,  ALP and  NAG in  
humans (Bazzi  et  al.,  2002; Westhyusen,  2003; Han,  2008) and dogs (Rivers et  
al., 1996; Heiene et al., 2001; Lee at al., 2012). The analysis of enzymes is usually 
methodologically straightforward and provides some prediction of the onset of 
impairment (Price, 1982; Westhuysen et al., 2003). Some LMW urinary proteins, 
such  as  ?2MG,  ?1-microglobulin,  RBP  and  cystatin  C,  together  with  IMW  and  
HMW  proteins  such  as  NGAL,  IL-18,  osteopontin  and  FABP  are  considered  as  
biomarkers of  kidney impairment in both humans (Hei et al., 2008; Askenazi et 
al., 2012; Arthur et al., 2013; Park et al., 2013; Zheng et al., 2013) and dogs (Raila 
et al., 2003; McDuffie et al., 2010; Smets et al., 2010; Vinge et al., 2010; Monti et 
al.,  2012;  Nabity  et  al.,  2012).  Kidney  injury  molecule  1  (KIM-1)  is  one  of  the  
investigated urinary markers for kidney injury in humans, rats and mice 
(Ichimura  et  al.,  1998),  but  no  evidence  of  its  usefulness  in  clinical  veterinary  
medicine has been reported. The evidence for the existence of KIM-1 protein in 
dogs and cats is scarce, merely occurring at the transcriptional level (UniProt, 
2013).   
Using the proteomic method, several promising urinary markers for 
different  kidney  impairment  conditions  have  been  found  in  both  humans  and  
animals. Some of the conventional urinary markers, such as ?1-microglobulin, ?2-
microglobulin, cystatin C, osteopontin and RBP, appear to be represented in 
these studies (Ho et al., 2009; Good et al., 2010; Varghese et al., 2010; Nabity et 
al.,  2011;  Bellei  et  al.,  2012).  Proteomics  has  been  able  to  suggest  novel  urinary  
markers  for  kidney  impairment,  such  as  fetuin-A  in  a  rat  model  as  well  as  in  
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human patients (Zhou et al., 2006), fumarylacetoacetate hydrolase (FAH) in a rat 
model of 4-aminophenol-induced kidney injury (Bandara et al., 2003), hepcidin-
25 in human AKI patients (Ho et al., 2009), ? defensin-1 in children suffering 
from contrast-induced nephropathy (CIN) (Bennett et al., 2008) and chitinase 3-
like  protein  1  (CHI3L1)  in  septic  AKI  in  a  mouse  model,  as  well  as  in  human  
septic AKI patients (Maddens et al., 2012).  
5.5 RENAL TOXICOLOGY 
 
Toxins can cause different degrees of kidney impairment, starting from minimal 
alterations in kidney function manifested as isosthenuria and proteinuria. Mild 
damage may be completely reversible. More severe consequences of 
nephrotoxicity include acute kidney injury with a significantly decreased GFR and 
are manifested as oligouria or anuria, proteinuria, aminoaciduria and glucosuria. 
Many potential nephrotoxic substances are therapeutic agents or originate from 
environmental exposure. Renal vulnerability to nephrotoxins varies between 
individuals depending on patient-specific, kidney-specific and drug-specific 
factors (Table 2). Nephrotoxicants can affect different sites in the kidney, 
hindering renal function via vasoconstriction (Sawaya et al., 1991), altered 
intraglomerular haemodynamics (Prendergast and George, 1993), tubular cell 
toxicity (Pallet et al., 2008), interstitial nephritis (Handa, 1986; Bennett et al., 
1996), crystal deposition in the tubular lumen (deSequera et al., 1996), 
thrombotic microangiopathy (Pisoni et al., 2001) and osmotic nephrosis 
(Visweswaran  et  al.,  1997).  In  the  histopathological  examination  of  kidneys  
suffering from toxicological insult, the major changes appear to be localized in the 
renal tubules, including the degeneration or necrosis of tubular cells, swelling of 
the epithelium, the detachment of tubular epithelial cells from the basement 
membrane, loss of the brush border, thinning of the epithelium, lumina dilation, 
casts  in  the  tubular  lumen,  and  rupture  of  the  tubular  basement  membranes  
(Solez et al., 1979; Lameire and Vanholder, 2000). 
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Table 2. Factors that increase the risk of toxicant-mediated acute kidney injury in 
humans, modified from Perazella 2009. 
 
Patient-specific factors Old age 
Pre-existing renal dysfunction 
Volume depletion 
Metabolic disturbances 
Immune response - genes 
Pharmacogenetics favouring drug toxicology 
Diabetes mellitus 
Kidney-specific factors High rate of blood delivery 
Increased toxin concentration in renal medulla and interstitium 
Reactive oxygen species (ROS) 
High metabolic rate of the loop of Henle 
Proximal tubular uptake of toxins 
Drug-specific factors Prolonged dosing periods and toxin exposure 
Potent direct nephrotoxicity 
Combination of toxins 
Overdose 
 
 
5.6 ADVERSE EFFECTS OF NSAIDS 
 
The  two  isoforms  of  cyclooxygenase  (COX),  COX-1  and  COX-2,  belong  to  the  
prostaglandin  G/H  synthase  family  and  serve  as  enzymes  that  convert  
arachnidonic  acid  to  PG (Vane  et  al.,  1998).  Constitutive  COX-1  is  expressed  in  
most  cell  types,  excluding  erythrocytes,  whereas  inducible  COX-2  is  primarily  
expressed in response to inflammation in many tissues. In addition, COX-2 has a 
constitutional role in the gastrointestinal tract, as well as reproductive and renal 
tissues (Dinchuk et al., 1995; Miller, 2006; Little et al., 2007). COX-1 is the most 
abundant isoform in the kidney, whose localization varies between species. 
Localization in the collecting ducts, renal vasculature and papillary interstitial 
cells  is  common  to  all  mammals  (Kömhoff  et  al.,  1997;  Khan  et  al.,  1998;  
Câmpean et al., 2003). The expression of COX-2 in the kidney is species-specific. 
In dogs and rats, COX-2 expression is focused on the thick ascending limb of the 
loop  of  Henle  and  macula  densa  (Harris  et  al.,  1994;  Khan  et  al.,  1998).  In  the  
adult  human  kidney,  COX-2  is  expressed  in  the  glomerular  podocytes,  parietal  
epithelial  and  smooth  muscle  cells,  and  medullary  capillaries  lacking  from  the  
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macula densa (Kömhoff et al., 1997; Therland et al., 2004). After release from the 
cell membrane phospholipids in response to acyl hydrolases, most notably 
phospholipase  A2,  AA  acts  as  a  precursor  molecule  for  eicosanoids.  The  COX  
pathway  converts  AA  to  cyclic  endoperoxidase  PGG2,  which  is  further  
transformed to another cyclic endoperoxidase, PGH2. These endoperoxidases are 
further transformed to different prostanoids, such as PGD2, PGE2 and PGF2?. 
Prostanoids play an important role in inflammation by inducing fever and 
hyperalgesia. COX-2-induced PGs also mediate inflammatory swelling and 
vasodilation, causing the principal signs of inflammation: redness, heat, swelling, 
pain and loss of function (Funk, 2001).    
NSAIDs are a group of drugs that provide analgesic, antipyretic and anti-
inflammatory  effects,  and  are  administered  in  both  humans  and  animals  with  
acute  and  chronic  pain  conditions.  Many  NSAIDs  are  chiral  molecules,  most  of  
which are manufactured in a racemic mixture. NSAIDs are mostly weak acids and 
highly  protein-bound  in  plasma.  They  are  usually  metabolized  in  the  liver,  and  
inactive metabolites are excreted in urine. The anti-inflammatory, antipyretic and 
analgesic  actions  of  NSAIDs  are  principally  mediated  by  the  inhibition  of  PG  
synthesis  at  the  cyclooxygenase  level  (Capone  et  al.,  2004).  NSAIDs  can  be  
classified by COX selectiveness into traditional NSAIDs (nonselective) and coxibs, 
which mainly affect cyclooxygenase-2 (COX-2). The selectivity of a given NSAID 
affects the prevalence of adverse effects (Layton et al., 2008; Patterson et al., 
2008). NSAIDs that possess greater inhibitory action on COX-2 than COX-1 have 
been regarded to be more beneficial,  since the synthesis  of  inflammatory PGs is  
hindered  but  the  cellular  protective  action  of  COX-1  products  is  spared  (Brune  
and Hinz, 2004). Some adverse effects of selective NSAID use have been reported 
in humans, such as an increased cardiovascular risk (Mukherjee et al., 2001) and 
an increased incidence of congestive heart failure (Ray et al., 2002).  
The most prominent side effect of NSAIDs is gastrointestinal (GI) irritation 
and ulceration in humans (Wallace, 1997), dogs and cats (Stanton and Bright, 
1989;  Hinton  et  al.,  2002)  due  to  the  inhibition  of  constitutive  COX-1.  Clinical  
signs include anorexia, depression, diarrhoea, vomiting, haematochezia and 
melena. Possible secondary manifestations of GI ulceration and bleeding include 
anaemia and hypoproteinemia in humans, which can be transient (Wilcox and 
Clark, 1997; Hreinsson et al., 2013). Renal side effects of NSAIDs in mammalians 
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can be functional (PG-dependent) or anatomic (PG-independent) by direct 
toxicity  (Bennett  et  al.,  1996;  Silverman  and  Khan,  1999;  Khan  et  al.,  2002;  
Kovacevic  et  al.,  2003;  Stern  et  al.,  2010).  Since  homeostatic  PGs  act  as  
vasodilators  in  the  kidney,  their  inhibition  by  NSAIDs  can  decrease  renal  
perfusion,  leading  to  acute  renal  vasoconstriction,  medullary  ischemia  and,  
ultimately, AKI (Oates et al., 1988).  The direct toxicity of NSAIDs is suggested to 
act through mitochondrial membrane permeability transition, which 
subsequently triggers cell death in kidney tissue (Mingatto et al., 1996; Uyemura 
et al., 1997; Hickey et al., 2001). The renal toxicity of NSAIDs is more common in 
dogs and rodents than primates (Bennett et al., 1996; Khan et al., 1998; Sellers et 
al., 2004). The reason for this could be the differences between species in renal 
COX-2 expression. 
5.7 ENVENOMATION BY VIPERA BERUS BERUS 
 
The  common  adder  (Vipera berus berus) is geographically widely distributed 
throughout  Europe  and  Asia  (Weinelt  et  al.,  2002;  Karlson-Stiber  et  al.,  2006),  
and  is  the  only  venomous  snake  in  Scandinavia.  Every  year,  many  domestic  
animals  are  bitten  by  common  adders. Viper  venom  is  produced  by  modified  
salivary  glands  and  stored  in  venom  sacks  near  the  fangs.  The  venom  of  the  
common  adder  is  a  yellow  liquid  that  contains  a  mixture  of  proteins  with  toxic  
and  enzymatic  properties  aiming  to  kill  or  immobilize  the  prey  and  assist  in  
digestion. Vipera species share characteristics at the familial and generic level in 
their venom composition, although the exact composition of Vipera berus berus 
venom is unknown. Variations in venom composition can be due to seasonal 
(Gubensek  et  al.,  1974),  individual  (Master  and  Kornalik,  1964;  Tan  and  
Ponnudurai, 1990; Georgieva et al., 2008) and geographical differences (Jayanthi 
and  Gowda,  1988).  In  a  study  on  Calloselasma rhodostoma (the Malayan pit 
viper),  it  was  noted  that  the  variation  in  venom  composition  can  also  be  
genetically  inherited  (Daltry  et  al.,  1996).  In  a  study  in  rabbits,  Vipera aspis 
venom  showed  a  terminal  half-life  of  12  h  in  the  circulation,  and  most  of  the  
venom  was  therefore  eliminated  within  three  days  of  envenomation,  but  only  a  
small percentage of the venom was found to be excreted in urine (Auderbert et al., 
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1993). In vitro and in vivo studies  have  demonstrated  that  snake  venom  of  
different species can be detected in kidney tissue after envenomation, and in 
some cases has a direct nephrotoxic effect (Ratcliffe et al., 1989; Burdmann et al., 
1993;  de  Castro  et  al.,  2004;  Mandal  and  Bhattacharyya,  2007;  de  Roodt  et  al.,  
2012).  A  study  in  which  purified  Russell’s  viper  venom-factor  X  activator  was  
injected into rats demonstrated that renal failure could be a result of 
intravascular clotting in the kidney microcirculation rather that direct toxic insult 
(Suntravat et al., 2011). 
 Snake venom L-amino acid oxidases (SV-LAOOs) are components in 
common adder venom that are believed to contribute to the venomous effect  by 
inducing apoptosis and haemorrhaging, and by affecting platelets (Tan and 
Ponnudurai,  1990; Li  et  al.,  1994; Suhr and Kim, 1996; Samel et  al.,  2006).  SV-
LAAO catalyses the oxidative deamination of L-amino acids, simultaneously 
promoting  the  release  of  hydrogen  peroxidase.  In  addition  to  SV-LAAO,  most  
Vipera venoms have phosphodiesterase, hyaluronidase, 5’-nucleotidase, 
phospholipase A2 (PLA2)  and  protease  activity  (Tan  and  Ponnudurai,  1990;  
Yukel’son et al., 1995).  
From common adder venom, metalloproteases and serine proteases 
degrading fibrinogen, faxtor X activators, and bradykinin-releasing serine 
proteases  have  been  identified  (Siigur  et  al.,  2002).  Snake  venom  
metalloproteases (SVMPs) participate in the haemorrhagic process, degrading 
endothelial cell surface proteins and extracellular matrix components (Fox and 
Serrano,  2005;  Escalante  et  al.,  2006).  PLA2s  are  lipolytic  enzymes  that  are  
divided into secreted (sPLA2s), cytosolic (cPLA2), Ca2+-independent (iPLA2), and 
lipoprotein-associated (LpPLA2) phospholipases A2 (Burke  and  Dennis,  2009).  
Snake venom PLA2s belong to the sPLA2s,  and they are further divided into two 
groups according to the position of cysteine residues in the sequence (Heinrikson 
et al., 1977). Snake venom serine proteases (SVSPs) catalyse the cleavage of 
covalent peptide bonds and therefore participate in digestion, the regulation of 
blood coagulation, the immune system and inflammation (Neurath, 1984).  
Hyaluronidase hydrolyses the hyaluronan, a part of the extracellular matrix, 
and  contributes  to  local  and  systemic  envenomation,  enabling  the  spread  of  the  
other  venom  components  (Tu  and  Hendon,  1983,  Girish  et  al.,  2002).  
Phosphodiesterases (PDEs) hydrolyse phosphodiester bonds from 
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polynucleotides, contributing to the generation of purine nucleosides, which can 
have a role in causing profound hypotension (Russel et al., 1963). 5’-Nucleotidase 
cleaves a variety of ribose and deoxyribose nucleotides, being most active against 
adenosine  monophosphate  (AMP).  Its  main  function  is  suggested  to  be  the  
release adenosine and other purines, resulting in the inhibition of platelet 
aggregation (Aird, 2002). Factor X activators activate coagulation factor X via 
cleavage, leading to the rapid formation of blood clots (Suntravat et al., 2011). 
In humans, the majority of reported snake bites cause no or very mild effects 
(Reading,  1996),  and  approximately  10%  of  cases  turn  out  to  be  so-called  dry  
bites,  meaning  bites  without  envenomation  (Petite,  2005;  Karlson-Stiber  et  al.,  
2006). Envenomation by Vipera berus berus can induce multiform symptoms. 
The  most  notable  local  symptoms  in  dogs  (Lervik  et  al.,  2010)  and  humans  
(Reading, 1996; Grönlund et al., 2003; Karlson-Stieber et al., 2006) are swelling, 
bruising  and  pain  in  the  area  of  the  bite.  In  more  severe  cases,  systemic  
symptoms  such  as  shock,  cardiovascular  and  gastrointestinal  symptoms,  CNS  
depression, AKI and respiratory distress occur in humans (Grönlund et al., 2003; 
Karlson-Stiber et al., 2006) and dogs (Lervik et al., 2010; Pelander et al., 2010).  
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6 AIMS OF THE STUDY  
The studies forming this thesis focused on finding and reviewing urinary markers 
associated  with  kidney  impairment  in  domestic  animals  after  a  toxic  insult  
resulting from exposure to an NSAID and common adder venom. The goal was to 
provide  evaluative  tools  for  kidney  function  assessment  based  on  laboratory  
analysis available in most veterinary clinics. 
 
The specific aims of these studies were:  
 
 
1. To determine the changes in urinary enzyme activities after NSAID 
overdose in sheep and envenomation by Vipera berus berus in dogs (I, V).  
 
2. To identify potential urinary markers associated with kidney impairment 
after  a  toxic  insult  resulting  from  NSAID  and  common  adder  venom  in  
domestic animals (II, III, IV).    
 
3. To  evaluate  whether  the  complement  system  has  a  role  in  renal  tissue  
destruction after an overdose of NSAID in sheep (III). 
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7 MATERIALS AND METHODS 
Study  protocols  I–III  were  approved  by  the  Ethics  Committee  of  the  Viikki  
Campus  at  the  University  of  Helsinki.  The  protocols  for  studies  IV  and  V  were  
pre-evaluated  and  approved  by  the  Ethics  Board  of  the  Faculty  of  Veterinary  
Medicine at the University of Helsinki.  
 
The methods used have been described in more detail in the respective 
publications (I–V). 
7.1 ANIMALS AND STUDY DESIGN 
7.1.1 SHEEP 
 
For  studies  I,  II  and  III,  twelve  female  Finnish  Landrace  sheep  were  purchased  
from a commercial breeder. All the sheep were >18 months old and none of them 
were  pregnant.  The  body  weight  of  the  animals  ranged  from  48.5  to  59.0  kg  
(mean 52.5 kg). The sheep were provided ad libitum access to good-quality hay 
and water before and during the experiment. The sheep were randomly allocated 
to a treatment or control group (n = 6 sheep per group). Sheep in the treatment 
group were intravenously administered an overdose of ketoprofen (30 mg/kg) at 
time point 0, which was equivalent to 10 times the therapeutic dose (3 mg/kg) for 
cattle.  The sheep in the control  group did not receive any injection,  since at  the 
time of the study it was considered that a placebo injection would not affect 
kidney function and was therefore unnecessary. 
7.1.2 DOGS 
 
For  studies  IV  and  V,  privately  owned  pet  dogs  were  used.  A  total  of  32  dogs  
accidentally bitten by Vipera berus berus and treated in the intensive care unit at 
the Veterinary Teaching Hospital of the University of Helsinki were recruited. 
The inclusion criteria were a strong suspicion of a viper bite (the owner saw the 
dog being bitten or saw a viper close to the dog), and clinical signs of a viper bite 
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defined as swelling and bruising in the bite area, pain and discomfort. A total of 
23 control  urine samples were obtained from clinically  healthy pet  dogs.  Eleven 
affected  dogs  and  eight  healthy  controls  were  included  in  study  IV,  and  all  the  
recruited dogs were included in study V.  
 
7.2 SAMPLES 
7.2.1 BLOOD 
 
Blood  samples  were  collected  into  tubes  containing  lithium  heparin  (I,  II,  III),  
citrate  (V),  and  into  plain  tubes  (IV,  V).  Samples  were  immediately  centrifuged  
(1300 g for  10  min)  and  plasma  or  serum  was  harvested.  An  aliquot  of  each  
sample was taken for clinical  chemistry analysis,  in which the concentrations of  
albumin, ALP, creatinine, GGT, total protein and urea (I, V), in addition to ACP 
and AST (I), were measured with a Konelab 30i analyser (Thermo Scientific). The 
rest of each sample was frozen at -80 °C for further use. 
7.2.2 URINE 
 
Sheep urine samples were collected before treatment and at two, four, six and 
eight hours after ketoprofen administration via a urinary catheter. The catheter 
was  inserted  just  before  the  injection  of  ketoprofen,  and  was  removed  after  8  
hours.  At  the  end  of  the  study  the  final  urine  sample  was  collected  via  
cystocentesis immediately after the sheep had been euthanized. Dog urine 
samples  were  collected  as  single  void  samples.  An  aliquot  of  each  sample  was  
taken  for  clinical  chemistry  analysis,  in  which  the  concentrations  of  creatinine  
and total protein and the activities of ALP and GGT (I, V), in addition to LDH (I), 
were measured with a Konelab 30i analyser. The results are expressed as ratios to 
the urinary creatinine concentration. The rest of the sample was centrifuged 
(1300 g for 10 min) to remove cellular debris and frozen at -80 °C until analysed. 
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7.2.3 TISSUE 
 
Kidney tissue samples were obtained from sheep (I, II, III) at the end of the study 
when the animals had been anesthetized with xylazine 0.2 mg/kg and ketamine 5 
mg/kg  IV  and  immediately  thereafter  sacrificed  with  T61.  A  part  of  the  tissue  
samples  was  placed  in  neutral-buffered  10%  formalin,  further  processed  by  
embedding in paraffin and sectioned into 4 or 7 µm thick slices. A further part of 
the tissue samples was snap-frozen in liquid nitrogen and stored at -80 °C for 
cryostat sections. 
7.3 ANALYTICAL METHODS 
7.3.1 ANALYSIS OF KIDNEY TISSUE 
7.3.1.1 Histological examination and immunohistochemistry 
 
The tissue samples in study I were sectioned and stained with haematoxylin–
eosin,  van  Gieson,  PAS,  and  von  Kossa  stains  for  histological  examination  via  
light microscopy. Paraffin slides (II) or cryoslides (III) were used to detect 
antigens  in  kidney  tissue.  To  visualize  bound  antibodies  (Table  3),  an  indirect  
immunohistochemical  procedure  was  used,  combining  a  polymer  technique  or  
streptavidin-peroxidase complex technique and nickel-enhanced DAB 
chromogen.  Negative  control  sections  were  processed  in  parallel  without  the  
primary antibody. 
7.3.2 ANALYSIS OF URINE 
7.3.2.1 SDS-PAGE and immunodetection 
 
In  studies  I,  II,  III  and  IV,  native  PAGE  or  SDS-PAGE  was  used  with  
polyacrylamide gels as described previously (Laemmli 1970). An equal amount of 
protein  from each  sample  was  loaded  onto  gels  and  proteins  were  separated  by  
electrophoresis at 100 V for 2 h. Proteins were transferred to a PVDF membrane 
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using semidry blotting apparatus. Immunodetection was performed by 
incubating blots with the appropriate primary antibody (Table 3) in a buffer of 1X 
Tris buffered saline (TBS) plus 0.1% Tween 20 after blocking the membrane with 
5% BSA for 1 h. Blots then were washed 3 times with 1X TBS plus 0.1% Tween 20 
and incubated with a horseradish peroxidase-conjugated secondary antibody in 
1X  TBS  plus  0.1%  Tween  20  at  the  appropriate  dilution  for  3  h  at  room  
temperature. The washing procedure was repeated and after the third wash, 
proteins were visualized using an enhanced chemiluminescent substrate and the 
signal  was  detected  with  a  Fuji  LAS-3000  high-resolution  CCD  camera.  In  
addition  to  the  immunodetection  of  C3c  (III),  the  detection  of  urinary  C3d  was  
performed from three AKI and four control sheep, C4c from two AKI and three 
control  sheep,  C5  from two AKI  and  three  control  sheep,  C9  from two AKI  and  
two control sheep, and C1q from three AKI and one control sheep. The results of 
these Western blots are presented in this thesis. 
 
Table 3. Antibodies used in immunostaining and Western blotting 
 
Primary 
antibody 
Host Application Dilution Source Publication 
MMP2 Mouse WB 1:1000 Chemicon I 
MMP9 Goat WB 1:1000 Santa Cruz I 
C1q Rabbit IHC, WB* 1:1000 Dako III 
C3c Rabbit IHC, WB 1:1500 Behring III 
C3d Rabbit IHC, WB* 1:1500 Dako III 
C4c Rabbit IHC, WB* 1:1500 Dako III 
C5 Goat IHC, WB* 1:1000 Quidel III 
C9 Goat IHC, WB* 1:1000 Quidel III 
Factor H Rabbit IHC 1:500 Quidel III 
Calbindin 
D28k 
Mouse IHC 1:1000 Abcam II 
CD1d Mouse IHC 1:1000 Abcam II 
SOD1 Rabbit WB 1:1000 Abcam IV 
AAT Mouse WB 1:1000 Santa Cruz IV 
Fetuin-B Mouse WB 1:1000 Abcam IV 
Abbreviations: IHC  Immunohistochemistry;  WB  Western  blotting;  *  not  
published previously. 
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7.3.2.2 Proteomic methods 
 
7.3.2.2.1 Two-dimensional gel electrophoresis 
 
In study II, the pooled urine samples were purified and concentrated with HPLC 
(Applied  Biosystems  400 HPLC,  Applied  Biosystems)  with  an  RPC column (GE 
Healthcare) and programmable absorbance detector (Applied Biosystem 738A, 
Applied Biosystems). Subsequently, the concentrations of proteins in the samples 
were measured by using a 2D Quant Kit (GE Healthcare).  
Proteins were analysed by two-dimensional gel electrophoresis (2DE) as 
described  by  O’Farrel  (1975)  as  follows.  An  IPG  strip  (pH  3–10:  7  cm)  (GE  
Healthcare) was used for isoelectric focusing. IPG strips were loaded with 7 µg of 
total  protein.  The  samples  were  focused  at  a  total  of  12  000  volt-hours  for  3  h.  
After focusing, the isoelectric strips were prepared for the second dimension gels 
by incubation in equilibrium buffer solution I (50 mM Tris pH 8.8, 6 M urea, 30% 
glycerol, 2% sodium dodecyl sulphate (SDS), 0.2% bromophenol blue, with added 
10mg/ml dithiothreitol  (DTT)) for 15 min.  This was followed by equilibration in 
buffer  solution  II  (50  mM  Tris  pH  8.8,  6  M  urea,  30%  glycerol,  2%  SDS,  0.2%  
bromophenol  blue,  supplemented  with  25  mg/ml  iodoacetamide)  for  another  15  
min. The prepared IPG strips were then placed on 12% sodium dodecyl sulphate 
polyacrylamide gels (SDS-PAGE) and sealed with overlay agarose (Bio-Rad). 
Electrophoresis was initiated at 50 V for 15 min, which was followed by 150 V for 
90 min. Gels were silver-stained without aldehyde. 
The  images  of  protein  spots  were  scanned  (Scanner  GS800,  Bio-Rad  
Laboratories) and spot intensives were obtained using the image analysis 
software PDQuest (Bio-Rad Laboratories). The images were normalized 
according  to  the  total  density  of  the  gel  and  by  comparing  spot  intensities  
between the samples.   
 
 
7.3.2.2.2 Two-dimensional difference gel electrophoresis 
 
 
In  study  IV,  urine  samples  were  concentrated  and  desalted  by  centrifugal  
ultrafiltration using Amicon Ultra-0.5 10 K centrifugal units (Millipore). In 
previously unpublished study with the urine samples collected before treatment 
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and  at  two,  four,  six  and  24  hours  after  treatment  from four  control  sheep  and  
four ketoprofen treated sheep, low-abundance urinary proteins in sheep urine 
were  first  enriched  using  a  bead-based  library  of  combinatorial  peptide  ligands  
(ProteoMiner,  Bio-Rad)  and  then  purified  using  a  2D  Clean  Up  kit  (GE  
Healthcare) before labelling. The samples were then precipitated with 
trichloroacetic acid-acetone and solubilized in 50 µl of labelling buffer (7 M urea, 
2 M thiourea, 4% CHAPS, 30 mM Tris). The samples were then labelled with Cy2, 
Cy3  and  Cy5  dyes  (CyDye  DIGE  Fluor  minimal  dyes,  GE  Healthcare)  after  
adjusting  the  pH  of  each  sample  to  8.5  if  needed.  The  dyes  were  added  to  the  
protein samples at a ratio of 50 ?g of protein per 400 pmol dye. Cy3 and Cy5 dyes 
were used to label the individual samples that were being compared, and Cy2 was 
used  for  the  internal  standard  consisting  of  equal  amounts  of  each  sample.  The  
labelling reaction was incubated for 30 min on ice in the dark and quenched by 
adding 1 mM lysine to the reaction following 10 min of incubation as earlier. The 
labelled samples were pooled and separated by two-dimensional gel 
electrophoresis. 
An  IPG  strip  (24  cm,  pH  3–10,  nonlinear,  GE  Healthcare)  was  used  for  
isoelectric focusing. Strips were rehydrated in 500 µl DeStreak rehydration 
solution  containing  1%  IPG  buffer  3-10  NL  (GE  Healthcare)  overnight  at  room  
temperature. Samples containing 150 µg of protein in total in 50 mM DTT, 4 mM 
tributylphosphine and 1% IPG buffer 3-10 NL were applied to the IPG strips with 
a  cup-loading  method  near  the  acidic  end  of  the  strips.  Isoelectric  focusing  was  
performed using IPGPhor (GE Healthcare) at 20 °C as follows: 3 h at 150 V, 3 h at 
300 V, then linear ramping to 10 000 V and 10 000 V for 50 000 Vh, with the 
maximum current per strip being 75 µA. The isoelectric strips were then prepared 
for  the  second  dimension  gels  by  incubation  for  15  min  in  equilibrium  buffer  
solution I.  This  was followed by equilibration for another 15 min in equilibrium 
buffer  solution  II.  The  strips  were  then  placed  on  12% sodium dodecyl  sulphate  
polyacrylamide gels (SDS-PAGE) and sealed with overlay agarose (Bio-Rad). 
Electrophoresis was initiated at 50 V for 30 min, which was followed by 400 V for 
3 h. The gels were scanned between low-fluorescence glass plates using an FLA-
5100 laser scanner (Fujifilm). After scanning, the gels were silver stained. The gel 
images were analysed and statistically assessed using DeCyder 7.0 software (GE 
Healthcare).  
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7.3.2.2.3 Protein identification by mass spectrometry 
 
Protein spots of interest were manually excised from the gels and digested in-gel 
using trypsin, allowing the peptides to be recovered. The peptides were then 
analysed by PMF. In study II, peptides were analysed by matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry (Autoflex MALDI-TOF 
MS, Bruker Daltonics). In study IV and unpublished study of low-abundant 
urinary proteins, MS/MS of peptides was performed on a hybrid quadrupole/TOF 
mass spectrometer with a Nanospray II source (QSTAR Elite, applied Biosystems, 
Foster City, CA). Proteins were identified using the local Mascot (Matrix Science, 
London, UK) against the in-house database of published mammalian sequences. 
The results were evaluated by considering the probability score, sequence 
coverage and correspondence between the estimated and the experimental pI and 
molecular weight. 
7.3.3 ASSESSMENT OF VIPERA BERUS BERUS ENVENOMATION IN DOGS 
7.3.3.1 Clinical gradation and kidney function score 
 
In study V, the clinical gradation of severity of envenomation was conducted with 
grading  scale  of  Audebert  et  al.  (1992)  with  modifications  by  Petit  (2005)  for  
common viper envenomation in human patients (Table 4). 
 
Table 4. Clinical gradation of common European adder envenomation in dogs by 
Audebert et al. (1992) with modifications by Petit (2005). 
 
Grade Envenomation Clinical feature 
0 Dry bite Fang marks, no local signs 
1 Minor Local swelling, pain, no systemic signs 
2 Moderate Extensive swelling and/or moderate systemic signs 
3 Severe Immense swelling and severe systemic signs 
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The severity of the impact on kidney function of Vipera berus berus 
envenomation  was  assessed  with  a  three-step  grading  scale  based  on  laboratory  
findings (Table 5). 
 
 
Table 5. Kidney function score based on laboratory findings of dogs bitten by the 
common European adder. 
  
Grade Laboratory findings  
1 Serum albumin, urea and creatinine within reference range in all samples taken 
2 Increased urine protein:creatinine ratio (>0.005) with slightly increased serum  
urea (8.8–16 mmol/L) and/or creatinine concentration (11–200 µmol/L) and/or 
decreased serum albumin concentration (<28 g/L) 
3 Serum creatinine concentration >200 µmol/L at some time point 
 
 
7.3.4 STATISTICAL ANALYSIS 
 
Statistical  analyses  (I,  V)  were  performed  using  PASW  Statistic  (IBM).  The  
normality  of  each  parameter  was  tested  with  the  Shapiro-Wilk  test,  and  
logarithmic transformation was performed when necessary before statistical 
analysis to obtain normally distributed data. In study I, differences in parameters 
between groups at various time points were analysed using the Mann-Whitney U-
test,  and  the  Wilcoxon  rank  sum  test  was  used  in  comparison.  In  study  V,  the  
Mann-Whitney U-test  was  used  for  comparison  of  nonparametric  data,  Pearson  
correlation was used for normally distributed data and Spearman rank 
correlation for nonparametric data. Significance was set at P <  0.05.  In  the  2D-
GE study (II), statistical analysis was performed with PDQuest (Bio-Rad 
Laboratories)  software  using  the  Student’s  t-test.  In  the  2D-DIGE  studies  (IV,  
unpublished study), statistical analysis was performed with DeCyder (GE 
Healthcare) software, in which a paired analysis of variation (ANOVA) method 
was  used  that  assigned  statistical  significance  to  the  differences  in  normalized  
protein abundance between each group. Protein spots demonstrating a minimum 
1.5-fold  difference  in  average  spot  volume ratios  between  groups  or  time  points  
and having a Student’s t-test P-value of less than 0.05 were picked and identified.   
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8 RESULTS 
8.1 NSAID OVERDOSE-INDUCED AKI 
8.1.1 VERIFICATION OF AKI 
 
 
The plasma concentrations of creatinine (I) and urea started increasing 4 h after 
injection and kept increasing until the end of the study. Plasma concentrations of 
creatinine exceeded the reference range of 6 to 8 h (median, 6 h) after ketoprofen 
treatment.  The  urinary  total  protein:creatinine  ratio  (I)  started  to  increase  2  h  
after injection, indicating proteinuria. These changes were not detected in the 
control group. Histological examination of kidney tissue after haematoxylin–
eosin,  van  Gieson,  PAS,  and  van  Kossa  staining  revealed  ATI  in  NSAID-treated  
sheep (I). In particular, proximal tubules showed lesions, including degeneration 
and  necrosis  of  individual  tubular  epithelial  cells.  Detachment  of  the  tubular  
epithelium from the tubular basement membrane, loss of the PAS-positive brush 
border, thinning of the tubular epithelial cells and interstitial oedema together 
with cellular debris and casts in the distal tubules were also detected. None of the 
above was detected in control sheep kidney tissues. Accordingly, these findings 
were considered as a sign of AKI induced by an overdose of ketoprofen. 
 
8.1.2 FINDINGS IN URINE 
 
 
Table  6  summarizes  the  findings  in  urine  measured  with  a  clinical  chemistry  
analyser (I). In addition to the results presented in Table 7, pro-MMP2 and active 
MMP2 increased in sheep with ketoprofen-induced AKI 6 h after administration. 
2D-GE analysis (II) revealed five upregulated proteins in sheep urine after AKI 
compared to control sheep urine (Table 7). From these identified proteins, 
apolipoprotein A1 (ApoA-1) appeared within both groups by the 2 h time point 
and  remained  visible  for  the  rest  of  the  time  points  for  both  groups.  Calbindin  
D28k and RPB4 appeared in the ketoprofen treatment group after 2 h and were 
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detectable  at  all  later  time  points,  being  absent  in  the  control  group.  CD1d  
appeared  in  the  ketoprofen  treatment  group  after  4  h  and  was  detected  at  all  
subsequent time points, being absent in the control group. In addition, 
haemoglobin was detected and identified in the urine of AKI sheep 2 h after the 
administration of ketoprofen. In unpublished 2D-DIGE analysis, three 
upregulated  proteins  were  identified  (Table  7,  figure  1).  The  MASCOT  search  
identified C3 and C4 as their complete forms, but the measured MWs were lower 
than the theoretical ones. This difference can be explained by the enzymatic 
cleavage of their inactive forms C3? and C4?.  Peptide fragments and amino acid 
sequences established by MS/MS analyses that indicate the enzymatic cleavage 
products are shown (figure 2). In Western blot analysis of urine (III), excretion of 
C3c was detected in both groups. The excretion patterns were similar in case and 
control  sheep,  showing  intact  C3  (~190  kDa)  and  its  degradation  products  C3b  
and  iC3b  (~180  kDa),  C3c  (~140  kDa),  C3?´75  kDa  (~75  kDa)  and  C3dg  (~50  
kDa).  The  excretion  patterns  of  C1q,  C3d,  and  C4c  were  similar  in  case  and  
control  sheep  in  Western  blot  analysis  (Figure  2).  The  detected  protein  band in  
the  anti-C1q  immunoblot  was  relatively  large  (~200  kDa),  and  was  above  the  
theoretical  size  of  the  C1q  protein  (~40  kDa),  suggesting  that  the  detected  C1q  
was  bound  to  other  proteins.  The  detected  protein  bands  in  the  anti-C3d  
immunoblot  matched  the  intact  C3  (~190  kDa),  and  the  degradation  products  
C3b (~170 kDa) and C3d (~40 kDa). Anti-C4c detected the intact C4 (~192 kDa), 
C4b (~80 kDa) and C4c (~75 kDa) (Figure 3).  
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Table  6.  Median  (range)  values  for  the  urinary  concentration  of  creatinine,  the  
protein:creatinine  ratio,  and  enzyme  activity  indices  in  samples  collected  from  6  
sheep with ketoprofen induced AKI and from 6 control sheep. 
 
Variable Group 0 h 2 h 4 h 6 h 8 h 24 h 
C
reatinine 
(m
m
ol/L) 
Ketoprofen 17.8  
(8.0–21.8) 
10.9  
(3.7–16.6) 
7.2  
(4.5-10)*† 
3.9  
(2.2–7.9)*† 
2.7  
(1.4–6.5)*† 
2.7  
(2.2–3.5)† 
Control 12.4  
(8.9–14.9) 
13.4  
(10.9–25.4) 
14.9  
(6.3–27.1) 
15.3  
(12.7–25.6) 
12.8  
(6.6–24.8) 
9.1  
(2.1–20.0) 
Protein:creatinine 
ratio (g/g) 
Ketoprofen 0.11  
(0.09-0.18) 
0.96  
(0.56-1.50)† 
7.72  
(4.09-19.6)*† 
18.0  
(6.69-63.1)*† 
27.2 
(3.05-
112.9)*† 
3.76  
(0.97–
16.5)† 
Control 0.14  
(0.08–0.38) 
0.49  
(0.18–1.38)† 
0.78  
(0.34–1.77)† 
1.41  
(0.38–2.67)† 
1.36  
(0.69–3.58)† 
0.77  
(0.23–
3.60)† 
G
G
T (U
/m
m
ol) 
Ketoprofen 0.86  
(0.50–1.18) 
0.86  
(0.79–1.38) 
1.66  
(0.49–4.20) 
3.02  
(1.27–8.17)*† 
6.17  
(2.62-
17.53)*† 
2.62  
(0.89–
16.13) 
Control 0.94  
(0.56–1.14) 
0.81  
(0.39–1.98) 
1.01  
(0.37–2.95) 
1.07  
(0.56–3.69) 
1.34  
(0.40–3.35) 
1.33  
(0.78–
2.93) 
A
LP (U
/m
m
ol) 
Ketoprofen 3.2 
 (1.9–5.0) 
4.3  
(1.9–9.7) 
13.9  
(9.4–42.4)*† 
42.3 
(27.7-
135.8)*† 
98.2 
(16.2–
420.8)*† 
27.4  
(8.7–
86.3)† 
Control 3.7  
(2.6–7.4) 
4.3  
(1.6–10.6) 
5.2  
(1.4–13.2) 
5.8  
(2.5–18.6) 
9.6  
(3.0–20.1) 
8.5  
(4.4–9.9) 
A
C
P (U
/m
m
ol) 
Ketoprofen 8.3  
(7.3–9.1)* 
13.9  
(9.9–22.2)*† 
26.8  
(11.9–
39.2)*† 
34.4  
(11.6–
53.8)*† 
30.9  
(9.3–56.5)*† 
9.5  
(8.7–
20.5)*† 
Control 7.1  
(6.8–8.1) 
7.2 
 (5.7–7.7) 
5.9  
(4.6–6.4)† 
6.3 
(5.3–6.8) 
6.1  
(5.8–8.1) 
7.5  
(7.1–9.6) 
LD
H
 (U
/m
m
ol) 
Ketoprofen 0.95  
(0.12–2.77) 
5.98 
(2.67–
22.64)*† 
51.05  
(0–150.46)† 
87.7 
(40.2–
228.2)*† 
185.2 
(28.2–
535.4)*† 
105.0 
(39.9-
305.7)*† 
Control 0.89  
(0–4.36) 
1.67  
(0–2.19) 
2.05  
(0.97–2.69) 
2.44  
(0.68–6.88) 
1.71  
(1.09–17.60) 
8.09  
(0–59.33) 
N
A
G
 (U
/m
m
ol) 
Ketoprofen 0.03  
(0.02–0.04) 
0.12  
(0.04–
0.26)*† 
NM 0.73  
(0.17–
1.40)*† 
NM 0.26 
(0.05–
0.60)*† 
Control 0.03  
(0.02–0.04) 
0.02  
(0.02–0.03) 
NM 0.02  
(0.02–0.04) 
NM 0.04  
(0.02–
0.15) 
*Within a time point within a variable, value differs significantly (P < 0.05) from the value for the 
control sheep. †Within a row, value differs significantly (P < 0.05) from the value for baseline.
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Table 7. Statistically significantly (P < 0.05) upregulated proteins in the urine of 
ketoprofen-overdosed sheep compared to controls detected by 2D-GE coupled with 
MALDI-TOF-MS (II) and 2D-DIGE coupled with LC-MS/MS (unpublished data). 
 
 
 Identified 
protein 
Accession 
number 
Theoretic
al pI/MW 
(Da) 
Matched 
peptides 
Sequence 
coverage 
(%) 
MASCO
T score 
Ratio 
2D
-G
E
 
Apolipoprotein 
A1 
P15497 5.71/28.4 11 35.2 106 NM 
Calbindin D28k P04467 4.7/29.9 4 19.2 51 NM 
Retinol-binding 
protein 4 
P18902 5.44/21.4 6 37.7 78 NM 
CD1d gi21893126
1 
6.09/38.4 4 30.7 54 NM 
Haemoglobin 
beta subunit 
gi16444867
4 
6.49/1603 9 46.2 115 NM 
2D
-D
IG
E
† 
Apolipoprotein 
A1 
P15497 5.71/28.4 38 64.15 636 4.39* 
C3? Q2UVX4 8.96/71.4 2 2.95 51 4.63* 
C4 ? P01030 
 
6.68/32.9 2 7.21 96 4.72* 
*Calculated between 2 h/ 0 h 
†Unpublished  
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Figure  1.  A  representative  image  of  a  2D-DIGE gel  after  silver  staining  showing  
protein spots successfully identified with LC-MS/MS that were significantly 
differently expressed between time points. Protein spots are marked by arrows 
and numbered: 1. Apolipoprotein A-1; 2. Complement component C3 ?; 3. 
Complement component C4?.    
Results  
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 A 
 1    mkptsgpsll llllaslpma lgn 
 23      pmysmit pnilrlesee tvvleahggq gtiqvsvtvh 
 61   dfpakkqvls nentqlnsnn gylstvtiki paskelksdk ghkfvtvvat fgnvqvekvv 
 121  lislqsgylf iqtdktiytp gstvlyrvft vdhkllpvgq tvfitietpd gipvkrdsks 
 181  sqnqfgiltl swnipelvnm gvwkikayye dspqqvfsae fevkeyvlps fevqlepeek 
 241  fyyiddpdgl kvniiarfly geqvdgtafv ifgvqdgdrr islthsltrv pindgngeai 
 301  lkrqvllngv qpsradalvg ksiyvsatvi lqsgsdmvea ertgipivts pyqihftktp 
 361  kffkpampfd lmvyvtnpdg sparhipvvt qgsnvqsltq ddgvaklsin tqnkrdplti 
 421  tvrtkkdnip egrqatrtmq alpyntqgns nnylhlsvpr velkpgetln vnfhlrtdpg 
 481  eqakiryyty mimnkgkllk vgrqyrepgq dlvvlpltit sdfipsfrlv ayytlinakg 
 541  qrevvadsvw vdvkdscmgt lvvknggkee khhrpgqqit lkieadqgar vglvavdkgv 
 601  fvlnkknklt qrkiwdvvek adigctpgsg rnyagvftda gltlktsqgl etqqradpqc 
 661  pqpat 
 666       rrrrs vqlmekrmdk agqyssdlrk ccedgmrdnp mkfpcqrraq filqgdacvk 
 721  afldcceyit qlrqqhsrdg alelarsdld ddiipeedii srsqfpeswl wtviedlkqa 
 781  dkngistklm nvflkdsitt weilavslsd kkgicvadpy evtvmqdffi dlrlpysvvr 
 841  neqveirail ynyreaenlk vrvellynpa fcslatakkr hqqtitipar ssvavpyviv 
 901  plkiglheve vkaavynhfi sdgvkktlkv vpegvrvnkt vavrtlnpeh lgqggvqree 
 961  vpaadlsdqv pdtesetkil lqgtpvaqmt edaidgerlk hliqtpsgcg eqnmigmtpt 
 1021 viavhyldst dqwekfglek rqeslelirk gytqqlafrq kssayaafqy rppstwltay 
 1081 vvkvfalaan liaidskdlc etvkwlilek qkpdgifqed gpvihqemig gfrdtrekdv 
 1141 sltafvlial heakdiceaq vnslgrsiak agdflenhyr elrrpytvai aayalallgk 
 1201 legdrltkfl ntakeknrwe epnqklynve atsyallall arkdydttpp vvrwlneqry 
 1261 ygggygstqa tfmvfqalaq yqkdvpdhke lnldvsiqlp srnsavrhri lwesasllrs 
 1321 eetkenerft vkaegkgqgt lsvvtvyhak lkgkvsckkf dlrvsirpap etvkkpqdak 
 1381 gsmildictk ylgdqdatms ildismmtgf spdvedlktl stgvdryisk yemnrdsnkn 
 1441 tliiyldkvs htvedclsfk vhqyfnvgli qpgavkvysy ynldetcirf yhpdkedgml 
 1501 sklchkdtcr caeencfmhh tekevtledr ldkacepgvd yvyktrliqk kleddfdeyi 
 1561 mvieniiksg sdevqvkqer kfishikcre alklkegahy lvwgvssdlw gekpkisyii 
 1621 gkdtwvelwp eaeecqdeen qkqcedlanf tenmvvfgcp n 
 
 B 
 1   nvnfqkaihe klgqytspva krccqdgltr lpmartceqr aarvqqpacr epflsccqfa 
 61  eslrkkartr gqvglarvgf svvpiaaaav slkvvargsf dfpvgdaisk ilqveregal 
 121 hreemvyeln pldplgrtle ipgnsdpnii pegdfksfvr vtasdpleal gsegalspgg 
 181 lasllrlpqg caeqtmtlla ptlaasryld kteqwsmlpp etkdravdli qkgytriqef 
 241 rkrdgsygaw lhrdsstwlt afvlkilsla qdqvxgsaek lqetatwlls qqrddgpfhd 
 301 pcpvihremq gglvgsdetv altafvvial hhglavlpdk nsrvensisr antflgakat 
 361 sgllgshasa itayalslte apedlrrvah nnlmamakdi gdklywgsvt tspsnvlspt 
 421 paprspadpi pqapamsiet taygllhlll wegkaeladq aaswltrqgs fqggfrstqd 
 481 tvvaldalsa ywiasytaee kglnvtlssl grsglkshvl qltnhqvhrl eeelqfslgs 
 541 kinvevrgns kgtlkvlrsy nvmdmtnttc qdlqievtvm ghveytmeae edyedyeyed 
 601 llagddpeah srxvtplqlf dgrrnrrrr 
 630          e apkaaeeres rvqytvciwr tgkvglsgma 
 661 iaditllsgf halradlekl tslsdryvsh fetegphvll yfdsvptsre cvgfgavqev 
 721 pvglvqpasa ilydyynpeh kcsvfygapr kskllstlcs advcqcaegk cprqrraler 
 781 gqqdlegyrm kfacysprvd ygfqvkvlre dsraafrlfe tritqvlhft kdagatadqt 
 841 rnflvrascr lqlepgkeyl imgldgatyd lkgdpqylld snswieemps ermcqstrhr 
 901 tpcaqlnsfl qeygtqxcq 
 
 
 
Figure  2.  Peptide  fragments  identified  by  MS/MS  and  sequence  coverage  of  
complement  C3  and  C4.  Complement  C3  (A)  and  complement  C4  (B)  amino  
sequences in one-letter code. C3 ? chain (23-665) and C4 ? (630-920) are framed 
with a box. Peptides identified by peptide mass fingerprinting are highlighted in 
bold and underlined.  
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Figure  3.  A  representative  image  from  Western  blot  analysis  of  the  urine  of  
control and ketoprofen-induced AKI sheep. The proteins were separated on 12% 
SDS-PAGE in non-reducing conditions and detected using polyclonal anti-C1q 
(A), anti-C3c (B), anti-C3d (C) and anti-C4c (D).   
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8.1.3 FINDINGS IN BLOOD 
 
Table 8 summarizes the findings in blood (I). Plasma ACP activity was increased 
after administration of ketoprofen at the 8 h time point compared to control 
sheep.  In  addition  to  these  variables,  the  serum  calcium  concentration  was  
significantly lower 24 h after ketoprofen administration than in control sheep 
(II). A decrease was noted in the concentrations of plasma ALP and GGT at the 24 
h time point compared to control sheep.  
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Table 8. Median (range) values for plasma concentrations of urea, creatinine and 
total protein, and albumin and activities of ALP, ACP and GGT in samples obtained 
from 6 sheep with ketoprofen induced AKI and from 6 control sheep. 
 
Variable Group 0 h 1 h 2 h 4 h 6 h 8 h 24 h 
U
rea (m
m
ol/L) 
Ketoprofen 5.3  
(3.9–6.9) 
5.2 
 (4.1–7.0) 
5.8  
(4.5–7.6)† 
7.2 
 (5.6-
8.8)*† 
8.8  
(6.6-9.6)*† 
9.8  
(7.1-
10.4)*† 
20.6  
(14.0–
22.3)*† 
Control 4.7 
 (3.5–5.2) 
5.3  
(3.8–6.3) 
4.9  
(3.6–6.1) 
4.6  
(3.7–5.7) 
4.1  
(3.4–5.7) 
3.4  
(2.8–5.0) 
4.1 
 (2.6–7.2) 
C
reatinine 
(µm
ol/L) 
Ketoprofen 86 
(80–106) 
88 
(79–105) 
89 
(82–109) 
120 
 (100–
140)*† 
151  
(131–
191)*† 
184 
 (150–
208)*† 
390  
(131–
414)*† 
Control 92 
(81–113) 
96 
(80–110) 
89 
(79–106) 
91 
(74–101) 
90 
(71–102) 
88 
(74–105) 
90 
(71–101) 
A
lbum
in (g/L) 
Ketoprofen 31.6 
(30.8–
32.6) 
31.5 
(31.0-
32.8) 
30.1 
(28.0-
31.1)*† 
29.6 
(28.6-
30.4)*† 
29.4 
(28.7-
31.5)*† 
28.6 
(27.6-
31.2)*† 
26.4 
(23.5–
31.9)*† 
Control 31.8 
(30.2–
33.9) 
31.9 
(30.3-33.1) 
31.6  
(30.7-
32.4) 
31.6 
(30.9–
32.8) 
32.6 
(30.1–
34.4) 
31.8 
(30.9–
32.8) 
32.0 
(30.8–
33.6) 
Total protein (g/L) 
Ketoprofen 64.8 
(61.0–
68.7) 
64.9 
(61.0-
66.5)† 
62.1 
(59.3-
63.1)*† 
60.1 
(56.4-
60.1)*† 
60.5 
(54.7-
66.0)*† 
57.6 
(52.0-
65.2)*† 
51.8 
(42.9–
68.1)*† 
Control 67.0 
(63.0–
69.5) 
66.2 
(63.4-
68.7) 
66.4 
(64.8–
68.2) 
66.5 
(63.7–
67.9) 
67.1  
(63.5–
72.3) 
67.0 
(64.8–
68.9) 
66.3 
(60.9–
68.3) 
A
LP (U
/L) 
Ketoprofen 229  
(175–296) 
196 
 (159–296) 
202  
(164–296) 
198 
 (131-
288)† 
205  
(136–302) 
186  
(128–312) 
121  
(72–312)*† 
Control 202  
(184–337) 
212  
(199–259) 
201 
 (189–252) 
186  
(167–276) 
203  
(187–266) 
201 
 (169–
300) 
200 
 (171–300) 
A
C
P (U
/L) 
Ketoprofen 3.8  
(3.4–4.1) 
NM NM NM NM 9.3 
(5.0–
11.2)*† 
7.5 
 (4.3–
10.2)*† 
Control 3.7  
(3.5–4.0) 
NM NM NM NM 3.8 
 (3.6–4.1) 
3.8 
 (3.4–3.9) 
G
G
T (U
/L) 
Ketoprofen 46  
(37–69) 
44  
(36–67) 
42  
(35–65)† 
43  
(35–62)† 
43  
(36–64)† 
40  
(34–59)† 
36  
(30–48)*† 
Control 46  
(41–52) 
45  
(40–49) 
47  
(41–50) 
47  
(41–51) 
48  
(42–50) 
46 
 (42–50) 
46  
(41–49) 
*Within a time point within a variable, value differs significantly (P < 0.05) from the value for the control sheep. 
†Within a row, value differs significantly (P < 0.05) from the value for baseline.
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8.1.4 FINDINGS IN KIDNEY TISSUE 
 
Immunostaining of the sheep kidney tissue with anti-calbindin D28k and anti-CD1d 
(II), and with anti-C1q, anti-C3c, anti-C3d, anti-C4c, anti-C5, anti-C9 and anti-factor 
H (III) revealed differences in staining patterns between the treated group and the 
controls  (Figure  4).  In  control  sheep  kidney  tissue,  no  signal  of  calbindin  D28k,  
CD1d,  C1q  or  factor  H was  detected,  as  the  basement  membranes  of  blood  vessels,  
epithelial  cells  in tubuli  and Bowman’s capsule in glomeruli  were positively stained 
for C3c.  In addition,  the tubulointerstitium in the medulla showed positive staining 
for C3d and distal convoluted tubules and proximal tubule epithelia in the cortex for 
C4c in control sheep. C5 and C9 were also present in proximal tubule epithelial cells 
in the medulla.   
After  ketoprofen  overdose  in  sheep,  the  deposition  of  C3c  was  more  intense  
compared to control sheep in the epithelial cells of proximal tubules in the medulla 
and in the tubular lumina. Similarly to control sheep, the kidney of the ketoprofen-
exposed  sheep  showed  positive  staining  for  C4c  in  distal  convoluted  tubules  and  
proximal tubule epithelia in the cortex. In addition, positive staining was also seen in 
proximal  tubules  in  the  medulla,  where  C4c  localized  in  epithelial  cells  and  
associated with cellular debris in the tubular lumina. C3d showed positive staining in 
the  proximal  tubule  epithelial  cells  and  in  tubular  lumen  in  the  medulla  in  all  
ketoprofen-overdosed sheep, and also in the distal convoluted tubules in the cortex 
in  two  ketoprofen-exposed  sheep.  C1q  was  found  in  the  proximal  tubules  in  the  
medulla  and  in  the  tubular  lumina  after  ketoprofen  overdose.  C5  and  C9  showed  
positive staining in the distal convoluted tubules and proximal tubule epithelia, and 
in the tubular lumina, intensifying from the cortex to the medulla. Factor H showed 
strong positive staining in the proximal tubules in the inner medulla in all  affected 
sheep. Two sheep with ketoprofen overdose also showed positive staining for factor 
H  in  proximal  tubules  in  the  outer  medulla  and  distal  convoluted  tubules  in  the  
cortex area. 
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Figure  4.   Immunostaining  of  kidney  tissue  of  sheep  with  ketoprofen  overdose-
induced AKI: 1A) cortex C1q; 1B) medulla C1q; 2A) cortex C3c; 2B) medulla c3c; 3A) 
cortex  C3d  3B)  medulla  C3d;  4A)  cortex  C4c;  4B)  medulla  C4c;  5A)  cortex  C5;  5B)  
medulla  C5;  6A)  cortex  C9;  6B)  medulla  C9  7A)  cortex  fH;  8)  medulla  calbindin  
D28k; 9)  medulla CD1d.  The arrowheads indicate the positively stained antigens in 
the  cortex  and  medulla  in  sheep  after  NSAID  overdose.  Figures  1A–7  are  
counterstained with hematoxylin–eosin. The original magnifications are 200X in 
Figures 1A–7A and 400X in Figures 8–9.  
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8.2 ENVENOMATION IN DOGS 
8.2.1 ROUTINE CLINICAL CHEMISTRY ANALYSIS, CLINICAL GRADATION AND 
KIDNEY FUNCTION SCORE 
 
Table 9 summarizes the findings in blood from dogs bitten by the common adder and 
treated  in  the  Veterinary  Teaching  Hospital  of  the  University  of  Helsinki.  The  
variation  in  all  variables  was  wide,  the  range  being  outside  of  both  minimum  and  
maximum reference values on the day of admission.  
Four of  the 34 dogs were assessed to suffer  from minor envenomation (grade 1)  
and 19 dogs from moderate envenomation (grade 2). Severe envenomation was 
encountered  in  9  dogs  (grade  3).  The  impact  of  envenomation  on  the  kidneys  was  
assessed  and  12  of  the  32  dogs  did  not  have  any  specific  findings  in  their  routine  
clinical chemistry analysis (grade 1), 15 showed mild deterioration (grade 2) and five 
of the dogs showed severe deterioration (grade 3) suggestive of kidney impairment. 
 
Table 9. Mean values together with standard deviation of plasma concentrations 
of total protein, albumin, creatinine and urea from dogs bitten by the common adder 
on the day of admission (day 1), and the highest value measured or the sample taken 
on the day after admission (day 2).  
 
Variable Day 1 
Mean ± SD  
(min–max) 
Day 2 
Mean ± SD  
(min–max) 
Reference range 
Total protein 49.0 ± 11.5 g/L  
(35–78 g/L) 
45.7 ± 9.2 g/L  
(32–65 g/L) 
58–77 g/L 
Albumin 28.4 ± 6.7 g/L  
(18.9–49 g/L) 
24.3 ± 6.1 g/L  
(12–36.5 g/L)   
30–41 g/L 
Creatinine 116.3 ± 114.9 µmol/L (27–
626 µmol/L) 
100.8 ± 106.4 µmol/L  
(40–564 µmol/L) 
57–116 µmol/L 
Urea 9.1 ± 8.6 mmol/L  
(2.1–39.6 mmol/L) 
7.8 ± 9.8 mmol/L  
(2.2–44.8 mmol/L) 
2.4–8.8 mmol/L 
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8.2.2 FINDINGS IN URINE 
 
In 2D-DIGE analysis (IV), seven proteins were significantly upregulated in the urine 
of  dogs  bitten  by  Vipera berus berus compared  to  the  control  group.  Five  of  them  
were identified by PMF: ?2MG, AAT, albumin, Fetuin-B and SOD1 (Table 10).  
 
Table 10. Proteins expressed differently (P < 0.05) in the urine of dog bitten by 
Vipera berus berus compared to controls, and detected by 2D-DIGE coupled with 
LC-MS/MS (IV). 
 
 
Identified 
protein 
Accession 
number 
Theoretic
al pI/MW  
Matched 
peptides 
Sequence 
coverage % 
MASCOT 
score 
Ratio 
AAT gi?121583756 5.58/46.3 24 16.2 558 3.05 
Albumin gi? 3319897 5.52/68.6 36 41.6 1043 2.73 
?2MG XP_535458 5.92/14.2 22 28.6 307 8.42 
Fetuin-B gi?74003556 5.64/42.3 8 37.1 478 4.4 
SOD1 Q8WNN6 5.69/15.6 9 21.6 235 2.66 
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Urinary b2MG, RBP4 and calbindin D28k were measured by ELISA analysis. 
The b2MG:creatinine ratio (mean ± standard deviation [min–max]) of nine dogs 
bitten by the common adder was 0.25 ± 0.22 µg/mg (0.04–0.78 µg/mg), while in 
the control dogs the index was 0.050 ± 0.007 µg/mg (0.04–0.05 µg/mg). The 
RBP4:creatinine ratio (median [min-max]) of dogs bitten by common adder was 
0.0018 (0.00–0.03) and that of control dogs 0.0028 (0.00–0.4). Urinary 
calbindin D28k was measured successfully only in six dogs bitten by Vipera berus 
berus,  but  in  all  control  dogs.  The  urinary  calbindin  D28k  ratio  to  creatinine  
(mean and CI) was 0.0065 (0.003–0.015) in dogs bitten by the common adder 
and 0.0045 (0.0009–0.020) in healthy control dogs. The urinary creatinine 
concentration was (geometric mean [CI]) 15 514.2 µmol/L (3023.3–34 785.4 
µmol/L)  in  control  dogs  and  2412.3  µmol/L  (556.9–5542.7  µmol/L)  in  dogs  
bitten by Vipera berus berus. Urinary  enzyme  activity  indices  and  
protein:creatinine ratios differed significantly (P < 0.001)  between  controls  and  
cases (Table 11). 
 
 
Table 11. Urine creatinine ratios of measured variables in dogs bitten by the 
common adder and healthy controls. 
 
 U-GGT:creatinine 
ratio* 
U-ALP:creatinine 
ratio* 
U-Protein: 
creatinine ratio* 
Control 
0.003 
(0.0007–0.0068) 
0.001 
(0.0004–0.0032) 
0.001 
(0.0002–0.0022) 
 
Case 
0.007 
(0.002–0.017) 
0.01 
(0.003–0.024) 
 
0.009 
(0.003–0.023) 
P <0.001 <0.001 <0.001 
*Geometric mean and confidence interval 
  
 
Positive correlations were recorded between urinary creatinine ratios of ALP, GT, 
and total protein. The envenomation grade correlated with urinary creatinine 
ratios of ALP (R = 0.642, P <0.001), GT (R = 0.619, P <0.001) and total protein 
(R = 0.669, P < 0.001). The kidney function score correlated with the urinary 
creatinine ratio of ALP (R = 0.603, P < 0.001).  
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9 DISCUSSION 
9.1 BLOOD VARIABLES 
 
The plasma concentration of  creatinine was significantly higher by 4 h after  the 
administration of  a  ketoprofen overdose in sheep in study I,  suggesting reduced 
kidney function. However, the creatinine plasma concentration did not exceed the 
RIFLE criteria for AKI in humans (Westhuyzen et  al.,  2003; Venkataraman and 
Kellum,  2007;  Endre  et  al.,  2008)  until  8  hours  after  the  initial  insult  to  the  
kidneys. As urine enzyme:creatinine ratios already showed a statistically 
significant increase two hours after the initial insult to the kidneys, it is suggested 
that  evaluation only based on plasma creatinine is  not a  sensitive marker in the 
early  diagnosis  of  AKI  in  sheep  exposed  to  an  overdose  of  ketoprofen.  The  
administered  dose  of  ketoprofen  was  10  times  higher  than  the  therapeutic  dose  
for  cattle  (3  mg/kg).  As  a  result,  the  sheep  developed  AKI  in  a  relatively  short  
period of time (<24 h). As the localization of COX isoforms in the sheep kidney is 
not  known,  it  is  unclear  how susceptible sheep kidney tissue is to ketoprofen. 
Therefore, it is unclear whether the given dose could mimic clinical settings for an 
accidental overdose of NSAID in clinical veterinary patients. In study V, in dogs 
bitten by Vipera berus berus,  the plasma creatinine concentration at the time of 
admission  was  above  the  reference  range  in  eight  (25%)  dogs  and  below  the  
reference  range  in  seven  (21.9%)  dogs.  It  was  also  noticed  that  the  serum  
creatinine concentration in dogs bitten by Vipera berus berus was not necessarily 
associated with the severity of the symptoms or measured urinary analytes. 
Comparing the sample taken on admission to the hospital with the highest value 
measured  or  the  sample  taken  the  day  after  admission,  the  plasma  creatinine  
concentration either increased or decreased in dogs bitten by the common adder. 
The same changes in serum creatinine were seen in dogs bitten by snakes having 
venom known to consist of cytotoxic or neurotoxic ingredients (Hrovat et al., 
2013). The evaluation of kidney function based on merely serum creatinine levels 
appears to be ineffective after common adder envenomation in dogs.     
In study I, both plasma albumin and total protein concentrations were already 
significantly lower in sheep with ketoprofen-induced AKI than control sheep two 
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hours  after  exposure,  and  the  concentrations  continued  the  decline  until  end  of  
the  study.  In  dogs  bitten  by  the  common  adder,  the  concentrations  of  albumin  
and total protein were substantially lower than the reference values. The decline 
in both analytes seen in sheep with ketoprofen overdose-induced AKI as well as 
dogs bitten by the common adder, associated with proteinuria, suggests increased 
excretion.  Plasma  leakage  from  the  blood  circulation  to  the  tissues,  the  
administered fluid therapy, or reduced albumin translation in the liver may also 
have contributed to the decreased plasma concentration of albumin.  
 
9.2 URINARY ENZYMES 
 
Studies I and V both suggested that urinary enzyme:creatinine ratios were 
sensitive  indicators  of  kidney  impairment.  Brush  border  enzymes,  such  as  ALP  
and GGT, are typically released into the urine during less severe injuries, 
compared with release of lysosomal or cytosolic enzymes (D’Amico and Bassi, 
2003; Westhuyzen et  al.,  2003).  In study I,  the increases in urinary activities  of  
the  lysosomal  enzymes  NAG  and  ACP  and  the  cytosolic  LDH  suggested  that  
relatively  severe  injury  to  tubular  cells  had  already  occurred  within  two  hours  
after the administration of ketoprofen. An increase in the urinary activities of ALP 
and GGT followed after that within four hours after administration. The 
concurrent decrease in plasma ALP and GGT activities detected after 
administration of ketoprofen suggested that some of these urinary enzyme 
activities  may  have  originated  from  plasma.  In  study  V,  the  urinary  ratios  of  
GGT:creatinine and ALP:creatinine differed significantly between affected and 
control dogs, supporting the findings in study I. According to a systematic review 
by  Coca  et  al.  (2008),  evaluation  of  urinary  GGT  activity  performs  well  in  the  
early diagnosis of AKI in humans. The association between urinary ratios of GGT, 
ALP  and  protein-to-creatinine  in  domestic  animals  with  toxic  insult  to  the  
kidneys  (I,  V)  supports  the  use  of  these  parameters  when  evaluating  possible  
kidney  impairment.  The  increased  urinary  creatinine  ratios  of  NAG,  ACP  and  
LDH (I) suggested tubular cell rupture and the release of these enzymes to urine. 
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9.3 URINARY PROTEINS 
In proteomic studies on urine after toxic insult to the kidneys by NSAID overdose 
or common adder envenomation (II, IV and unpublished data), several proteins 
were  found  to  be  upregulated.  The  majority  of  identified  proteins  had  a  low  
molecular weight, suggesting that both NSAIDs and common adder venom cause 
tubular  injury.  A  disadvantage  in  gel-based  proteomics  is  that  very  basic,  low-
abundance or hydrophobic proteins are difficult to observe. In addition, 
developing proteinuria contains large amount of albumin, which may hide some 
of the emerging low-abundance proteins. To overcome this, urine samples were 
pretreated  with  a  bead-based  library  of  combinatorial  peptide  ligands  
(unpublished data) (ProteoMiner, Bio-Rad) as described earlier (Candiano et al., 
2012). As the venom of the common adder contains several ingredients that have 
the  capacity  to  degrade  extracellular  matrix  components,  it  is  possible  that  
proteinuria  after  envenomation  was  at  least  partly  caused  by  glomerulus  
impairment. From the identified low-molecular-weight proteins, RBP4, ?2MG 
and  AAT  are  well  known  markers  of  kidney  impairment  in  both  humans  and  
animals (Raila et al., 2000; Bianchi et al., 2001; van Hoek et al., 2008; Maddens 
et al., 2010; Metzger et al., 2010). 
9.3.1 COMPLEMENT COMPONENTS 
 
Several antigens were localized in the tubular epithelium and lumen in 
immunohistochemical  studies on kidney tissue (II,  III)  after  ketoprofen-induced 
AKI.  Histological  examination  (I)  revealed  ATI  in  sheep  administered  an  
overdose  of  ketoprofen.  Further  examination  with  antibodies  against  C1q,  C3c,  
C4c,  C5,  C9,  and  factor  H placed  the  expression  of  these  antigens  mainly  at  the  
site of ATI. The differential expression between control and AKI sheep for all 
antigens indicated that these proteins either directly contribute to kidney 
destruction or are a secondary manifestation of it. AKI with different preliminary 
causes  may  share  common features,  and  this  is  well  recorded  in  ischemic,  toxic  
and sepsis-induced AKI, where hypoxia plays a role (Heyman et al., 2012).  
Complement components are believed to have a leading role in 
proteinuria-associated tubulointerstitial injury (Sheerin and Sacks, 2002). 
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Complement activation is  associated with a large variety of  renal  disorders with 
proteinuria  in  both  humans  and  animals,  such  as  glomerulonephritis,  renal  
infarction, ischemia-reperfusion injury and IgA nephropathy (Meri et al., 1992; 
Väkevä et al., 1995; Farrar et al., 2006; Jang and Rabb 2008; Onda et al., 2011). 
The complement system consists  of  soluble and membrane-bound proteins,  and 
it  contributes  strongly  in  the  mediation  of  inflammation,  tissue  clearance  and  
protection against infection (Müller-Eberhard, 1988; Walport, 2001). Some of the 
circulating  C3  originates  from  the  tubular  compartment  in  the  kidney,  but  the  
majority  of  complement  C3  in  plasma  is  synthesized  in  the  liver  (Tang  et  al.,  
1999).  The excretion of  complement components C3 and C4 was increased after  
NSAID-induced AKI (unpublished data).  The MASCOT search identified C3 and 
C4 as their complete forms, but the measured MWs were lower than theoretically 
calculated  for  both  C3  and  C4  (<72  kDa).  The  increase  in  excretion  may  be  a  
result of gain of expression of C3 and C4 in tubular epithelial cells, together with 
enzymatic cleavage products of C3 and C4. Complement regulatory proteins such 
as  factor  H,  membrane  cofactor  protein  (MCP)  and  decay  accelerating  factor  
(DAF) inhibit further activation of the C cascade in the normal kidney (Pangburn 
et  al.,  1981;  Ichida et  al.,  1994; Timmerman et  al.,  1996; Gerritsima et  al.,  1997;  
Yamada  et  al.,  2004).  The  main  soluble  inhibitor  of  the  alternative  pathway,  
factor H, binds to the cell surface and together with factor I breaks down C3b to 
an inactive form (Zipfel et al., 1999). Proximal tubular cells, which have very low 
expression  of  membrane-bound  complement  regulators  such  as  DAF  and  MCP,  
bind factor H, yet excess plasma proteins can prevent the interaction (Buelli et al., 
2009).  
In the case of renal inflammation, or in proteinuric diseases, the synthesis 
of  C3  in  the  kidney  increases  (Sacks  et  al.,  1993;  Montinaro  et  al.,  2000).  
Activated C proteins cluster in the epithelium of proximal tubules after 
proteinuria in humans (Camussi et al., 1983; Biancone et al., 1994; Gerritsma et 
al., 1997) and rats (Eddy et al., 1989; Nomura et al., 1997). The end product of C 
activation  is  the  formation  of  C5b-9   (membrane  attack  complex,  MAC),  which  
comprises one molecule each of C5b, C6, C7 and C8, and one or more molecules 
of C9  (Müller-Eberhard 1988). MAC adheres to the cell membrane and induces 
cell injury and apoptosis (Biancone et al., 1994).  
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The  positive  immunostaining  of  C3c,  C4c,  C1q,  C5,  C9  and  factor  H  in  
kidney  tissue  after  ketoprofen-induced  AKI  (III)  principally  occurred  in  the  
proximal tubular epithelial cells and in the tubular lumen, but also to some extent 
in  the  distal  convoluted  tubular  epithelial  cells.  This  finding  implies  that  
intrarenal synthesis of complement components could promote the progression 
of ketoprofen-induced AKI. Our study cannot confirm whether MAC was formed, 
but the positive immunostaining for complement components, especially C5 and 
C9, suggests that the MAC complex is formed and is at least partly responsible for 
the cell injury seen in tubular cells after NSAID overdose.  
9.3.2 OTHER PROTEINS 
 
AAT and ?2MG were detected in study IV in dogs bitten by the common adder.  
They  are  both  freely  filtered  by  the  glomerulus  and  normally  reabsorbed  in  the  
tubules, and are therefore considered to be markers of tubular injury (Yanagisawa 
et  al.,  1983;  Herget-Rosenthal  et  al.,  2004).  AAT is  an  acute-phase  glycoprotein  
produced in the liver, and secreted into the bloodstream. It belongs to the serine 
protease inhibitor (SERPIN) family, contributes to the regulation of proteolysis 
and  protects  the  extracellular  matrix  during  inflammation  (du  Bois  et  al.,  1991;  
Gettins, 2002). AAT protects kidney tissue by anti-apoptotic and anti-
inflammatory routes in renal ischemic/reperfusion injury (Daemen et al., 2000). 
?2MG belongs to the major histocompatibility complex (MHC) class I molecules 
and  is  filtered  by  the  renal  glomerulus  (Schardijn  and  Statius  van  Eps,  1987).  
?2MG is reabsorbed from epithelial cells of the proximal tubules by megalin- and 
cubilin-mediated endocytosis and is degraded to amino acids (Schardijn and 
Statius  van  Eps,  1987;  Verroust  et  al.,  2002).  RBP4  is  the  specific  carrier  of  
vitamin  A  in  plasma.  When  bound  to  vitamin  A  it  forms  a  complex  with  
transthyretin, increasing the molecular weight of RBP4 and preventing its loss in 
the kidney glomeruli (Kanai et al., 1968, Naylor et al., 1999). Released RBP4 is 
freely filtered by the glomerulus and reabsorbed by the proximal tubule cells 
(Peterson  et  al.,  1970),  and  its  increased  concentration  in  urine  may  thus  also  
suggest a malfunction of this process.  
The other identified low-molecular-weight proteins, i.e. calbindin D28k (II), 
CD1d (II), fetuin-B (IV) and SOD1 (IV), participate in various biological functions 
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and are also all expressed in the kidney tissue (Canchis et al., 1993; Marklund et 
al., 1982; Takada et al., 1982; Fredericks and Bosch, 1997; Denecke et al., 2003; 
Brigl  and  Brenner,  2004).  Two  of  these  proteins  were  connected  to  NSAID  
overdose-induced  AKI:  calbindin  D28k  and  CD1d  (II).  Calbindin  D28k  is  a  
cytosolic vitamin D-dependent calcium-binding protein and is expressed in the 
distal convoluted tubule, where calcium reabsorption is regulated (Parmentier et 
al., 1987). The positive immunostaining of calbindin D28k in the sheep kidney 
tubules after ketoprofen overdose (II) supports the theory that the excretion of 
calbindin D28k is likely to stem from disrupted epithelial cells. 
CD1d  is  expressed  on  cell  surfaces  and  belongs  to  non-polymorphic  major  
histocompatibility complex (MHC) class I-like molecules (Bilsland et al., 1991). In 
the kidney, the expression of CD1d is concentrated in the glomeruli and some of 
the  tubules,  and  in  smooth  muscle  surrounding  blood  vessels  (Canchis  et  al.,  
1993). Antigen-presenting cells expressing MHC class I-like molecules such as 
CD1d  are  presented  to  NKT  cells  in  the  kidney,  among  a  large  variety  of  other  
tissues (Brigl and Brenner, 2004). The positive immunostaining of CD1d in sheep 
kidney  after  an  overdose  of  ketoprofen  (II)  suggests  that  NKT  cells  could  be  
present  in  renal  tissue  after  toxic  insult.  The  expression  of  CD1d  in  tubular  
epithelial  cells  and  tubular  lumina  suggests  that  the  excreted  protein  may  
originate from the epithelial cells. Yang et al. (2011) reported that human patients 
with  an  unknown  aetiology  of  ATN  had  NKT  in  kidney  tissue,  particularly  
localized  in  the  tubulointerstitial  area,  and  the  number  of  NKT  cells  varied  
according  to  the  severity  of  ATN.  Several  studies  involving  mouse  models  have  
also connected NK and NKT cells to tubular injury (Li et al., 2007; Zhang et al., 
2008;  Satpute  et  al.,  2009;  Yang  et  al.,  2011).  The  role  of  innate  immunity  in  
NSAID-induced  AKI  remains  uncertain,  although  the  occurrence  of  CD1d  and  
complement proteins implies it. 
The  two  other  proteins  found  in  urine,  fetuin-B  and  SOD1,  were  associated  
with  common  adder  envenomation  (IV).  Fetuin-B  is  a  small  (42.3  kDa)  
extracellular protein originating from the liver that inhibits cysteine-type 
endopeptidase activation. It belongs to the cystatin superfamily of proteases and 
is  a  paralogue  to  fetuin-A,  sharing  some  of  the  functions  (Olivier  et  al.,  2000;  
Denecke  et  al.,  2003).  Some  snake  venoms  contain  endopeptidases  (Tu  and  
Toom, 1967; Bottrall et al., 2010), and the manifestation of fetuin-B in the urine 
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of  dogs bitten by the common adder (IV) may thus indicate that  common adder 
venom also contains endopeptidase activity. The most probable origin of excreted 
protein is plasma, where fetuin-B is released from the site of cell rupture.  
Copper/zinc  superoxide  dismutase  (SOD1)  is  a  small  (15.06  kDa)  cytosolic  
enzyme belonging to a metal-containing enzyme family that catalyses the 
dismutation  of  superoxide  anions  and  is  expressed  in  all  mammalian  tissues  
(Marklund et al., 1982; Takada et al., 1982; Fredericks and Bosch, 1997). These 
enzymes  act  as  the  most  important  line  of  antioxidant  defence  against  ROS,  
metabolic  by-products  that  can  lead  to  oxidative  stress  (Zelko  et  al.,  2002;  
Johanson  and  Giulivi,  2005).  Oxidative  stress  has  been  associated  with  snake  
envenomation  in  humans  and  mice  (Yamasaki  et  al.,  2008;  Zengin  et  al.,  2012;  
Santhos et al., 2013). Since venom of the common adder contains SV-LAOOs that 
promote the release of hydrogen peroxidase, it is probable that excretion of SOD1 
is related to oxidative stress in envenomed dogs. The excreted SOD1 probably at 
least  partly  originates  from  plasma,  where  it  is  released  from  the  site  of  cell  
rupture. It may also be leaked from disrupted kidney cells.  
In  studies  I,  II  and  III  with  the  sheep  model  of  AKI,  some  changes  in  the  
urinary protein profile were also detected in the control group. The urinary 
protein  concentration  and  proenzyme  MMP-2  activity  also  slightly  increased  in  
some control  sheep  (I),  apolipoprotein  A1  appeared  in  the  urine  of  both  groups  
(II) and the excretion pattern of complement proteins was identical between 
groups  (III).  These  findings  hint  that  the  urethral  catheter,  which  remained  in 
situ for  eight  hours,  may  have  caused  local  irritation  in  the  lower  urinary  tract,  
and therefore contributed to these urinary variables.  
 
9.3.3 FUTURE PROSPECTS 
 
Based on the studies included in this thesis, and as suggested earlier (Decramer et 
al.,  2008;  Thongboonkerd,  2010),  urine  appears  be  a  good  choice  of  sample  
matrix for detecting kidney impairment. The urinary creatinine ratios of ALP, and 
GGT (I, IV), together with LDH, ACP and NAG (I), could be reliable variables for 
diagnosing kidney impairment in its early stage. The redeeming feature of these 
urinary  enzymes  is  that  their  measurement  is  often  conducted  with  a  clinical  
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chemistry analyser, which is readily available for most clinical sites. Several of the 
proteins detected in sheep or dog urine after toxic insult by proteomic methods 
(II, V and unpublished data) warrant further investigation with clinical veterinary 
patients suffering from kidney impairment. The ELISA analysis of urinary ?2MG 
in  dogs  bitten  by  the  common  adder  and  control  dogs  supported  the  2D-DIGE  
results  (IV).  Analysis  of  urinary  RBP4  and  calbindin  D28k  proved  to  be  
challenging  and  failed  to  function  with  urine  from  dogs  bitten  by  the  common  
adder.  More  research  with  a  larger  set  of  clinical  samples  and  a  wider  range  of  
methods is needed to validate the potential AKI biomarkers reported in this 
thesis.  
Concerning the criteria of a good biomarker of AKI (Nguyen and Devarajan, 
2008), urinary enzymes together with urinary calbindin D28k and RBP4 were 
upregulated in the early stage of kidney impairment after toxic insult (I,II). 
Although most of the detected proteins suggested tubular injury in the sheep and 
dog studies, glomerular impairment may also been manifested. To distinguish 
between glomerular and tubular injury, urinary enzymes ACP, ALP, GGT, LDH 
and NAG (I) together with calbindin D28k, RBP4, (II), AAT, and ?2MG (IV) 
detected with proteomic methods appear to accurately reflect tubular injury. 
None of the urinary proteins reported in this study could definitely distinguish 
renal and nonrenal injury, although urinary fetuin-B and SOD1 found in dogs 
bitten by the common adder may indicate nonrenal tissue destruction related to 
the snake venom impact. The increase in urinary activities of the lysosomal 
enzymes NAG and ACP, and the cytosolic LDH in sheep after toxic insult may 
serve as a tool for assessing the severity of tubular injury.  
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10 CONCLUSIONS 
 
1. Changes in activities of several enzymes were detected, and these changes 
proved  to  be  sensitive  markers  for  kidney  impairment  after  NSAID  
overdose in sheep and envenomation by Vipera berus berus in dogs. 
 
2. Several new potential urinary markers, such as calbindin-D28k, CD1d, 
C3?, C4?, SOD1 and Fetuin-B, were detected together with those 
previously reported in the literature (RBP4, ?2MG and AAT) after a toxic 
insult resulting from NSAID or common adder venom. 
 
3. Complement activation participates in kidney tissue destruction after an 
overdose of  NSAID in sheep,  and components of  the complement system 
can be detected in kidney tissue and urine. 
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